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ABSTRACT 
Many signal transduction pathways are regulated by guanine nucleotide-binding (Gα) 
proteins, which function as molecular switches fluctuating between active and inactive 
conformations. Proper function depends on three flexible switch regions that are involved in the 
relatively slow hydrolysis of GTP. Deep sequencing studies have found mutations in the GNAS 
and GNAI1 genes involved in tumorigenesis, among which include a mutation corresponding to a 
highly conserved arginine residue in the switch II region. A mutation in GNAI1 encoding an 
R208Q change in Gαi1 has been linked to intestinal cancers. We investigated the molecular basis 
of oncogenesis of this mutant by studying the kinetics of nucleotide binding and single-turnover 
GTP hydrolysis. We demonstrated that, relative to the corresponding wild-type proteins, this 
mutation hindered nucleotide exchange; however, the rate of GTP hydrolysis was lower in 
R208Q Gαi1. The R208Q Gαi1 mutant was crystallized and its X-ray structure was compared to that 
of the wild-type protein and was also used to conduct molecular dynamics simulations. These 
studies suggested that changes in the rates of hydrolysis can be attributed to alterations in the 
microenvironments of the nucleotide binding site which seemingly destabilize the switch II 
region but do not perturb the surface of the protein. The mutation presumably results in a 
decrease in the production of the secondary messenger cAMP via its interaction with the 
effector adenylyl cyclase that might promote oncogenesis in tumor cells. Furthermore, we 
investigated the folding and structural integrity of the protein with three spectroscopic 
 xvii 
techniques. We showed that for the mutant, both the active and inactive conformations have 
similar melting temperatures, which are comparable to the inactive conformation of the wild-
type protein but lower relative to the active conformation. 
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CHAPTER ONE 
CELL SIGNALING AND THE HISTORY OF G-PROTEINS 
Complex organisms are composed of a remarkably complex network of individual cells 
working harmoniously to form what we know as life. Cell signaling is central for survival and is 
the relay of messages between cells, which are involved in everything from cell division to 
apoptosis. A signaling molecule, such as a hormone or a neurotransmitter, binds to an 
extracellular receptor. It then transmits the signal to the inside of the cell using a variety of 
intermediary proteins that function as binary switches, alternating between “on” and “off” states 
that propagate the signal via secondary messengers. Guanine nucleotide-binding proteins (G-
proteins) are among the most common signal transducing proteins found in the cell.  
Alfred Gilman and Martin Rodbell conducted the initial landmark studies on G-proteins. 
Their work was deemed so important that they received the Nobel Prize in 1994 in Physiology or 
Medicine (1-3). All G-proteins are involved in signaling but differ in their mechanisms and are 
classified as either monomeric small GTPases, such as the Ras superfamily, or larger 
heterotrimeric membrane-bound proteins (4). This study will focus on the latter.  
Heterotrimeric G-proteins 
Heterotrimeric G-proteins are comprised of an  (G),  (G), and a  (G), subunit and work 
synergistically with a heptahelical transmembrane receptor protein, a G-protein coupled 
receptor (GPCR) (4). In the resting state, the GDP-bound G trimer interacts with a GPCR. When 
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the GPRC becomes stimulated, a conformational change in the G subunit occurs that causes it 
to release GDP and bind GTP, which further leads to the dissociation from the G subunits and 
the receptor (Figure 1). The active G•GTP diffuses along the membrane until it reaches an 
effector, which then uses secondary messengers to induce a response inside the cell. The signal 
terminates when the bound GTP hydrolyzes to GDP at which point the G complex is reformed 
(Figure 1). GTPase activity, which requires a Mg2+ cofactor, is relatively inefficient to permit 
adequate signal propagation. Therefore, the intensity of the signal is dependent on the time it 
takes G to hydrolyze GTP to GDP (4-6).  
Humans have roughly 865 different GPCRs that elicit different cellular responses using 
relatively few G-protein complexes (7). There are 16 G genes that encode 23 different proteins, 
5 G genes that encode 6 proteins and 12 G genes (7). G proteins vary widely in their function 
and expression patterns and are classified into four subfamilies according to sequence 
homology: Gs, Gi, Gq, G12 (Table 1) (4, 8-11). Gαi1 (and to a lesser extent Gαs) are the primary 
focus of this research.  
The α Subunit 
Gα proteins are highly conserved and found in almost all eukaryotes (12). Sequence 
similarity between G proteins vary between 35% and 95% but all are composed of two domains: 
a GTPase domain and a -helical domain (Figure 2). The GTPase domain is structurally and 
mechanistically similar to the small monomeric GTPase family of G-proteins and is comprised of 
five -helices surrounding six-stranded -sheets at the core (5). Beginning at the N-terminus, 
each individual α-helix are numbered α1-α5 and each β-sheet as β1-β6 (Figure 2). 
  
3
 
  
Figure 1. Schematic representation of the pathway of G-protein coupled receptor signaling. 
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Table 1. Families of Gα subunits and their effects on cell signaling. For further detail see (4). 
Gα protein Expression  Receptor(s) for Effector(s) Cellular Response 
Gαs - subfamily     
    Gαs (S, L) Universal Adrenalin, noradrenalin, dopamine, glucagon Adenylyl Cyclase  cAMP ↑ 
    Gαolf Olfactory cells Odorants Adenylyl Cyclase  cAMP ↑ 
Gαi - subfamily     
    Gαi1 Neuronal cells Noradrenalin, prostaglandins, opiates Adenylyl Cyclase  cAMP ↓ 
    Gαi2 Universal Noradrenalin, prostaglandins, opiates Rap1, GAP cGMP ↓ 
    Gαi3 
Nonneuronal 
cells Noradrenalin, prostaglandins, opiates GRIN1, GRIN2 cGMP ↓ 
    Gαt1 Rods Photons cGMP-PDE cGMP ↓ 
    Gαt2  Cones Photons cGMP-PDE cGMP ↓ 
Gq - subfamily     
    Gαq Universal 
Acetylcholine, serotonin, vasopressin, 
epinephrine PLC Ca2+ ↑ 
G12 - subfamily     
    Gα12  Universal LPA, thrombin PLD NO ↑ 
    Gα13 Universal LPA, thrombin iNOS  NO ↑ 
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The GTPase domain contains the active site where there are five highly conserved sequences 
necessary for binding of the nucleotide and the cofactor. The diphosphate binding P-loop 
(GXGESGKS) and the guanine ring binding motifs (NKXD) and (TCAT) bind the guanine nucleotide 
while two conserved motifs (RXXTXGI) and (DXXG) anchor the Mg2+ cofactor (4, 5).  
Also of importance in the GTPase domain are the three flexible regions known as 
switches I, II, and III. The switches are the most dynamic regions of the protein and reside near 
the  - phosphate of GTP; their positioning is dependent on the type of nucleotide that is bound 
(Figure 2 shown in green). In the inactive conformation, the switches are unordered which allows 
for GDP to escape the active site (13, 14) but upon binding to GTP, switches II and III  become 
more rigid and form a lid over the nucleotide (15, 16). Switches I and II are also important 
interfaces with G for the formation of the heterotrimer (17), and interact with effectors in some 
instances (18-20). Finally, the N-terminus in the GTPase domain also undergoes a post-
translational modification and becomes lapidated. Gαi1 becomes myristoylated by myristoyl CoA 
while Gαs becomes palmitoylated by palmitoyl CoA (21-23). In the case of Gαi1, the N-terminus is 
unordered but upon myristoylation, forms an ordered α-helix (21, 22, 24). The myristol group, a 
14-carbon fatty acid, attaches to a glycine residue at the N-terminus via an amide bond, which 
allows the G subunit to interact with the Gβγ complex via the Gγ subunit and anchor the complex 
to the membrane (21, 24-26).  
The α-helical domain contains six α-helices designated by letters A through F with A being 
closer to the N – terminus and F being near the C – terminus (5). Interestingly, there is less 
homology amongst Gα proteins in the  helical domain, which enhances the specificity of G 
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proteins to distinct receptors and effectors (27, 28). The  helical domain also gives the G-
protein an increased affinity for guanine nucleotides (29, 30).  
GTPase activating proteins (GAPs) are proteins that add an additional layer of regulation. 
The binding of a GAP (such as regulator of G – protein signaling 4 [RGS4]) to a Gα protein 
enhances the GTPase activity and promotes GTP hydrolysis (31, 32). GTPase rates can be as 
much as 1000 fold higher when a GAP is present (33).  
Mechanism of GTP Hydrolysis  
 Conceptualizing a mechanism for GTP hydrolysis has proven to be challenging. Gα 
proteins contain highly conserved catalytic residues that act to stabilize charge build-up around 
GTP. Furthermore, Gαi1 proteins properly position a water molecule for a nucleophilic attack near 
the γ – phosphate of GTP (Figure 3). The transition state of GTP during its hydrolysis is not well 
understood due to the presence of d orbitals on the phosphorous atom of the γ-phosphate. 
Furthermore, it is not known if the mechanism of hydrolysis is associative, dissociative, or a 
combination thereof (34, 35). An associative transition state would utilize a base that would 
remove a proton from a molecule of H2O at the active site, priming it for a nucleophilic attack on 
the γ – phosphate. Conversely, a dissociative mechanism would involve bond cleavage between 
the terminal phosphates resulting in a shift in negative charge from the γ to the β phosphate 
causing the γ – phosphate to become a stable leaving group (35). There are two highly conserved 
residues in the switch II region of Gα proteins that could accomplish this (6). In wild-type Gαi1 
(WTGαi1), Glutamine (Q) 204 and the carbonyl functional group of glycine (G) 203 are in a 
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position to facilitate such a mechanism. Similarly, arginine (R) 187 in the switch I region has been 
shown to be critical for catalytic activity (36-38).  
The βγ Heterodimer 
The G and the G subunits are always complexed together, as there are no known 
instances in which they are separated. There are five known G isoforms numbered 1-5, and 
each is composed of seven β-sheets oriented in the shape of a propeller, and an α-helix at the N-
Figure 3. Key interactions that facilitate GTP hydrolysis. 
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terminus. There exist 12 G isoforms, numbered 1-12, that consist of two α-helices connected by 
a loop (39, 40). The G and G subunits have two points of contact: 1) at their N-terminal, helices 
as well as an interaction between β5/β6 of the G subunit, and 2) at the C-terminal, the α-helix 
of the G subunit. Many possible combinations between G and G subunits are possible (41). 
Specificity is dictated by regions on the G subunit as small as 14 residues (42). Upon activation 
of the G-protein, the G separates from the G complex and, similarly to the G subunit, 
continues to relay the signal through interactions with effectors (39).  
The Adenylate Cyclase Effector 
Each cell relies on a myriad of signaling pathways to incite changes within the cell to an 
ever-changing environment. Effectors are responsible for the production of a secondary 
messenger necessary to invoke a response to an extracellular stimulus. A common effector acted 
on by both the G subunit and the G complex is adenylyl cyclase (AC). AC is a membrane-bound 
protein that catalyzes the conversion of adenosine triphosphate (ATP) to cyclic adenosine 
monophosphate (cAMP) and pyrophosphate (PPi) which acts as a secondary messenger. To 
propagate the signal, cAMP activates protein kinase A (PKA), which in turn promotes glucose 
metabolism (43, 44). Alternatively, cAMP will bind exchange factor directly activated by cAMP I 
(EPAC) which has many intracellular targets involved in cell proliferation (45-49). There are 10 
known isoforms of AC, each of which is composed of two pseudo-symmetrical transmembrane 
domains referred to as C1 and C2 (50).  
AC is a unique effector in that it is both activated (Gs) and inhibited (Gi1) by a G 
protein. Both G subunits are structurally similar and a comparison of the two crystal structures 
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results in a 1.07 Å root mean square deviation (RMSD) between the Cα atoms (22). It is therefore 
surprising that Gαs and Gαi1 interact with different AC subunits using distinctly different motifs 
and have opposite effects on the activity of AC. Scanning mutagenesis of Gαs identified important 
residues for the activation of AC located on the switch II and α4β6 loop (51). Further studies that 
solved the crystal structure of active Gs complexed with AC and the non-hydrolyzable GTP 
analog GTPγS (Gs•GTPγS•AC) revealed that the interaction occurs between the switch II region 
of Gs and the C2 domain of AC. The interface between Gαs and AC includes the following 
residues: leucine (L) 272, asparagine (N) 279, arginine (R)280, tryptophan (W) 281, L282, R283, 
threonine (T) 284, R231, R232, glutamine (Q) 236, and N239 (52). To date, crystallization of the 
Gi1•GTPγS•AC complex has not been reported. Unlike Gs, Gi1 requires the post-translational 
addition of a myristoyl fatty acid in order to bind AC, making it more difficult to crystallize. 
Nonetheless, evidence suggests that Gi1 interacts exclusively with C1 of AC while Gs interacts 
solely with C2 (22). Because of the structural similarity between Gs and Gi1, it is reasonable to 
presume that Gi1 switch II and α4β6 loop regions interact with the AC C1 domain in a similar 
manner. Point of contact residues between Gαi1 and AC have been experimentally determined 
as: arginine (R) 208, lysine (K) 209, isoleucine (I) 212, K312, R313, K314, K315, T316, and 
glutamate (E)318 as the residues involved in binding to AC (52-54).  
Folding of G-Proteins and Disease States 
Folding Overview 
Eukaryotic organisms rely on intercellular signaling for all biological processes, including 
growth, senescence and apoptosis. Aberrations in proteins involved in signal transduction can 
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affect protein folding, catalytic function, or protein-protein interactions. This can lead to 
aberrant cellular signaling, which is the basis for several human diseases.  
Folding is crucial for the structural integrity of proteins and directly responsible for their 
physiological function. Protein folding is an elegant process in which a nascent protein co-
translationally folds into a higher order structure. Although it is not fully understood, it is thought 
to proceed through an energy landscape that includes multiple pathways with a variety of 
intermediates, or molten globules, each one with progressively lower free energy (55-57). The 
native structure at the end of the path has the lowest free energy and is, therefore, the most 
stable (Figure 4). Under denaturing conditions, a protein will unfold, altering the secondary 
structure and revert to a molten globule state, which may retain some activity (58, 59). 
Furthermore, molten globules that are high in β-sheet content pose an increased risk for 
aggregating and amyloid fibril formation, which are described in many devastating diseases such 
as Alzheimer’s and Huntington’s disease (60-62). In vitro studies using thermal or chemical 
denaturants are physiologically unrealistic, but suitable methods for the investigation of the 
relative stability of a wild-type protein compared to a mutant as the non-covalent interactions 
are altered, causing different unfolding properties for each protein (63, 64).  
G-Proteins and Cancer 
Cancer is the second most common cause of death in the US and ranks similarly across 
the rest of the developed world (65). Neoplastic disease is defined as the uncontrolled growth of 
cells and can occur in nearly every tissue type. Tumorigenesis starts in cells carrying a repitoir of 
genetic alterations that lead to aberrant cellular signaling. This aberrant signaling will often result 
12 
 
in accelerated growth and inhibition of apoptosis signaling, allowing diseased cells to be further 
propagated. Furthermore, since several of these genetic alterations result in inactivation for DNA 
repair pathways, diseased cells accumulate additional genetic changes with time, which is 
thought to be one mechanism of multidrug resistance. Some genetic changes are germline, i.e., 
inherited and therefore exist in every cell in the body. However, the vast majority of genetic 
alterations are somatic, as they originate in a single cell after birth.  
Cancer-related, genetically-altered genes can affect tumorigenesis or tumor progression 
and are classified as being either oncogenes or tumor suppressor genes. When oncogenes 
become mutated, they are endowed with a gain of function to often evade inhibitory signals and 
are aberrantly activated. Tumor suppressor genes are genes involved in the suppression of 
growth and the promotion of senescence and apoptosis. These genes are mutationally 
inactivated or deleted in cancers (66, 67).  
GNAI1 and GNAS are two oncogenes that encode the Gαi1 and Gαs proteins, respectively 
(68). The R208Q mutation in the switch II region of Gαi1 has been associated with colorectal 
cancer (68). The corresponding mutation in Gαs is R231H, which has been linked with 
neuroectodermal tumors (68). G-proteins have been implicated in various diseases, including 
bipolar disorder (69-71) and McCune-Albright syndrome (72) but are one of the most highly 
targeted protein families in drug design because of their association with human cancers (68, 73-
77). 
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Spectroscopic Techniques Used for Studying Gα Proteins 
Fluorescence Spectroscopy 
Fluorescence is a radiative decay process in which an excited molecule releases a photon 
as it returns from the ground vibrational level of the first excited state to the ground state 
(Figure 5A). The energy difference between the excited state and the ground state is quantized 
and governed according to the equation: ΔE = h*ν where ΔE is the energy change, h is Planck’s 
constant and ν is the frequency. A more convenient expression to relate ΔE to the wavelength (λ) 
utilizes the speed of light constant (c): ΔE = h*c*λ-1. Not every molecule has this ability, but the 
ones that do are considered fluorophores.  
Figure 4. Schematic representation of the energy landscape during folding. Reused with permission 
from (57). 
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Fluorophores are typically organic compounds that contain conjugated π-bonds. In 1954, 
Weber and Laurence studied the environmental effects on fluorescence intensity (78). Their 
work involved many polycyclic organic compounds. They found that, in water, they did not 
fluoresce, but became fluorescent upon the addition of serum albumin. Their work paved the 
way for small molecule fluorescent dyes and one of the dyes they worked with was 8-
anilinonaphthalene-1-sulfonic acid (ANS) (Figure 5B, inset). Weber and Laurence found that the 
quantum yield and the Stoke’s shift were dependent on the polarity of the solvent. A less-polar 
solvent such as octanol caused the maximal wavelength (λmax) to become shorter, creating a blue 
shift while increasing the quantum yield (79). The opposite is true for ANS in a more polar 
solvent such as ethylene glycol (Figure 5B). The shift in the wavelength at maximal absorbance 
(Δλmax) is explained by comparing the dipole moment of the excited state versus the ground 
state. The dipole moment of the excited state can be considerably different from the ground 
state due to distinct electron distributions. Typically, the excited state has a larger dipole 
moment causing it to become more polar relative to the ground state. In a hydrophobic solvent, 
this leads to a disruption of the dynamics within the solvent’s environment, rendering it less 
stable, thereby increasing the energy gap between the excited state and the ground state (Figure 
5A).  
The effects of solvent on quantum yield (i.e. fluorescence intensity) are a result of 
intersystem crossing. Electrons in the ground state are paired with opposite spins. When an 
electron becomes excited, it retains its spin initially and is in a singlet state. Polar environments 
interact more with the excited state and facilitate a spin conversion to the triplet state resulting   
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Figure 5. Jablonsky diagram outlining the process of fluorescence. A) A fluorophore is excited at a given 
wavelength (blue arrow) and emission occurs at a lower wavelength (green and red arrows). The solvent 
can affect the energy of the photon. Used with permission from (79). B) The wavelength is blue shifted 
and the intensity increases as the fluorophore (ANS – structure shown in top right of diagram) is placed 
in different solvents of decreasing polarity. Recreated from (78). 
 
A) 
B) 
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in unpaired electrons. A transition from the triplet state to the ground state is forbidden, 
resulting in a slower internal conversion to the ground state without the emission of a photon 
causing a lower fluorescence intensity.  
Gilman and coworkers used these phenomena to obtain an indirect measurement of G-
protein activity by monitoring the intrinsic tryptophan fluorescence following the addition of 
GTPγS, a non-hydrolyzable analog of GTP (80, 81). Tryptophan (W) is a highly conjugated residue 
that contains a large degree of overlap between its p-orbitals, rendering it a fluorophore. As the 
protein moves into the active conformation, the W microenvironments change to become more 
hydrophobic and the intensity increases as a result (82). Gα proteins are not consistent with the 
number of tryptophan residues they contain. For example, Gαt contains two tryptophan residues 
while Gαi1 and Gαs have three and four, respectively. While tryptophan residues are generally 
seen at the core of the protein, they are distributed around the protein at various frequencies 
and therefore, do not equally contribute to the change in the overall fluorescence.  
Chabre et al. (83) determined that Gαt could be placed in an active conformation by the 
addition of tetrafluoroaluminate (III) (AlF4-) and that this method of activation was a zero order 
reaction. The AlF4- mimics the γ phosphate so the GDP is left in place and the rate is not 
dependent on the exchange, unlike activation with GTPγS. Henceforth, activation using AlF4- and 
Mg2+ will be referred to as AMF activation. Additionally, Chabre (84) investigated the 
contribution of the two-tryptophan residues in Gαt towards the overall fluorescence in the 
protein. Using tryptophan mutants, Chabre found that W207, rather than W127, was primarily 
responsible for the change in fluorescence (in Gαt, W207 is in the switch II region, but W127 is 
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not). Furthermore, activated Gαt•AMF and Gαt•GTPγS exhibited an increase in fluorescence 
intensity vs Gαt•GDP that was accompanied by a red shift of λmax (83, 84). 
Using intrinsic tryptophan fluorescence, Hamm and co-workers (85) found Gαi1•AMF also 
exhibited a red shift. Analysis of crystal structures of Gαi1•GDP (86) and Gαi1•AMF (16) reveals 
that W211 is a part of the switch II region that moves from an unordered state to an ordered 
state upon binding of AlF4-. The new environment is more hydrophobic, which would normally 
coincide with a blue shift. Therefore, this observation was unexpected. It was later determined 
that the red shift arises from the formation of a π – cation interaction between W211 and R208 
in the active conformation (85). Electrostatic interactions can form within a protein between 
residues bearing a positive charge (such as lysine and arginine) and ones with π – electron 
systems (such as phenylalanine, tyrosine, and tryptophan). The electrons are distributed more 
with the sp2-hybridized carbons of a ring structure, creating a partial negative charge toward the 
interior of the ring and a partial positive charge around the edge (Figure 6) (87-90). The strength 
of this interaction is dependent on the distance and the angle between the residues, and 
typically range from 1 – 5 kcal*mol-1 (91). Other interactions such as π – π stacking between π – 
electrons of nearby residues interact with each other (92), and less common, π – anion 
interactions have also been described (93, 94), in which a negatively charged residue such as 
aspartate or glutamate interacts with the π – electrons of a nearby residue.  
Najor et al. (95) determined the contribution of each of the three-tryptophan residues in 
Gαi1 to the overall change in fluorescence. Gαi1 contains three tryptophan residues: W131 in the 
α-helical domain, W211 in the switch II region, and W258 in the GTPase domain. They found that 
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the W211F mutant abolishes the change in fluorescence while the W131F mutant showed an 
increase in the change of fluorescence. The W258F mutant had a change in fluorescence similar 
to WT (95).  
Fluorescence is a useful technique for studying Gα proteins because it offers a tool to 
probe both structural and functional characteristics. The overall structure can be monitored 
during thermal denaturation as the fluorescence signal decreases and eventually disappears 
when the protein is fully unfolded. Similarly, by monitoring the red shift, the π-cation interaction 
reveals information about the structural integrity. Functionally, the changes in conformation 
from the inactive to active correlate to the changes in fluorescence intensity.   
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A) 
C) 
B) 
Figure 6. A) The carbons that form the benzene ring have a higher electronegativity than the hydrogen atoms they are bound to creating a 
partial negative at the center of the ring. B) A positive charge can interact with the center of the benzene ring where the partial negative 
charge has formed. C) The electrostatic potential map of six benzene derivatives illustrating the charge distribution. Part C) reused with 
permission from (94) 
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Ultraviolet/Visible Spectroscopy 
Ultraviolet/visible (UV/Vis) spectroscopy is a commonly used technique for studying 
proteins and quantifying protein concentrations. UV/Vis spectroscopy is similar in theory to 
fluorescence spectroscopy. While fluorescence spectroscopy considers the relaxation of an 
excited electron to the ground state, UV/Vis spectroscopy focuses on the transition from the 
ground state to the excited state and measures the absorption of light at a given wavelength 
within the ultraviolet-visible light spectrum. Similar to fluorescence, the difference in energy is 
given by the equation: ΔE = h*c*λ-1 while the absorbance is given by the Beer-Lambert Law: 
A=ε*c*l where ε is the molar extinction coefficient, c is the concentration, and l is the path 
length. Although the wavelength of a photon that a molecule can absorb is quantized, broad 
peaks in a UV/Vis spectrum are common that arise from different vibrational and rotational 
states that change the energy difference.  
Three amino acid residues contain conjugated structures that absorb light in the UV/Vis 
region and therefore can act as chromophores: tryptophan (W), tyrosine (Y), and phenylalanine 
(F). Phenylalanine shows the lowest absorption and absorbs at a wavelength of 260 nm with an 
extinction coefficient of 125 M-1 *cm-1. Tryptophan and tyrosine both absorb at 280 nm but 
tryptophan has a higher extinction coefficient (5690 M-1 *cm-1 vs 1280 M-1 *cm-1) and therefore 
absorbs more light than tyrosine. Although tryptophan absorbs more light, they are relatively 
uncommon relative to the frequency of tyrosine residues making the latter more relevant. The 
extinction coefficient of a polypeptide can be estimated simply from the sum of multiplying the 
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number of tryptophan and tyrosine residues by their respective extinction coefficient. Gαi1 has an 
extinction coefficient of 36,495 M-1 *cm-1 (96).  
Gαi1 has thirteen Y resides and three W residues (Figure 7). Unfolding a protein causes the 
chromophore residues to become more exposed, allowing them to absorb more light leading to 
a hyperchromic effect. Melting temperatures (Tm) can be deduced from the midpoint of the 
change in absorption as the protein unfolds.  
Circular Dichroism Spectrophotometry  
Circular dichroism (CD) uses circularly polarized light to determine the secondary 
structure of a polypeptide. Light consists of the sum of an electric and a magnetic component. 
Polarization occurs when each of the two components is limited to one respective plane normal 
to each other. Most common is linear polarization, which occurs when the two wave functions 
are in phase with each other. Circular polarization is when one of the wave functions is out of 
phase by 90 ° (Figure 8A). Circular dichroism results from a chiral molecule (e.g. polypeptide) 
interacting with one polarized state more than the other. CD is affected by the overall structure 
of the macromolecule, rather than the individual chiral centers, and each secondary structure 
has a signature pattern. An α-helix has a high absorption at 190 nm and then goes into a valley 
and creates a double hump between 210 nm and 230 nm. In contrast, a β-sheet starts out at a 
much lower absorption and decreases into a single hump (Figure 8B and C).  
Quantifying the concentration of each type of secondary structure species requires the 
aid of computer algorithms that use a set of reference proteins of known structure to analyze 
  
2
2 
Figure 7. Crystal structure of Gαi1 bound to GTPγS depicting the various residues that are 
key for spectral analysis (PDB: 1GIA). The three-tryptophan residues (cyan) contribute to 
the change in fluorescence as the conformation changes from inactive to active. Thirteen 
tyrosine residues are used in UV/Vis (pink). 
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A) 
C) 
Figure 8. A) Schematic representation depicting the vertical and horizontal phases of a wave to illustrate circularly polarized 
light. B) Common secondary structures in proteins. C) The α-helix (red) produces a signature double hump pattern in a CD 
spectrum while a β-sheet (blue) shows only a single hump. Random coils (black) start with a negative ellipticity that then turns 
positive. 
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the spectrum (97). This approach is necessary for determining the secondary structure content 
of WT Gα proteins and mutants at different stages of unfolding. 
Project Aims 
 The overall goal of this research is to gain insight into why the R208Q mutation in Gαi1 
promotes tumor growth. A better understanding of the biology of this mutant protein may lead 
to better therapeutic options for patients whose cancers harbor mutations in this gene (68). The 
specific aims addressed in this dissertation are as follows: 1) structural analysis of the R208Q 
mutant and comparison with the WT protein; 2) determination of functional activity of the 
R208Q mutant and how the mutation affects the rate of GTP hydrolysis vs WT; and 3) elucidation 
of mechanistic consequences of the R208Q mutation.  
We began by studying the structural properties of wild-type (WT) and mutant Gαi1, with 
the ultimate goal of gaining insight into how changes in the structural properties of the mutant 
proteins promotes neoplastic disease.  
We used several biophysical techniques to study the WT and the R208Q mutant of Gαi1 in 
three conformations (Gαi1•GDP, Gαi1•AMF, Gαi1•GTPγS) to better understand the global 
structures of these proteins. Fluorescence spectroscopy is able to take advantage of the 
relatively uncommon tryptophan residues at the core of the protein, as it can be used for 
monitoring the conformation of the protein as it transforms from the inactive to the active 
conformation. We further used UV/Vis spectroscopy to study protein unfolding, by monitoring 
the absorbance of tyrosine residues on the surface of the protein. In order to obtain an 
appreciation for the global structural changes, we turned to CD, as it monitors the types of 
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secondary structures present in the protein. Taken together, these three techniques offer a 
glimpse into the structural integrity of the protein characterized by melting temperatures (Tm). 
Gα proteins hydrolyze GTP at an inefficient rate with turnover times that are 
exponentially slower than other enzymes. In this respect, Gα proteins are not considered 
enzymes but have evolved with this trait to provide time to propagate their signal. In the case of 
Gαi1, the duration in the active state is directly related to the cellular concentrations of the 
secondary messenger cAMP. Studying the rates of GTP hydrolysis is necessary to determine 
downstream effects of the R208Q mutation. Fluorescence spectroscopy can be used to monitor 
the conformation as the protein goes from the inactive conformation to the active GTP-bound 
conformation and back as it hydrolyzes GTP. Malachite green is a dye that binds inorganic 
phosphate (Pi) that results from GTP hydrolysis, and is quantifiable via UV/Vis spectroscopy as 
the bound and free malachite green absorb light at different wavelengths. The combination of 
these techniques offers a parallel analysis of GTP hydrolysis and are used in conjunction to 
determine a more accurate rate of GTP hydrolysis.  
We turned to in silico computational analysis to study the interactions within the protein 
to investigate the consequences of the R208Q mutation on an internal relay between key 
residues involved in normal function. This approach has been an invaluable resource for 
integrating the structural data with the functional GTP hydrolysis results. 
Cancer is a complicated disease, with each patient harboring a unique milieu of genetic 
alterations leading to aberrant cellular function. Modern cancer therapies exploit unique protein 
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products or signaling properties of diseased genes. Because of the large variety of genetic 
alterations, there is a constant need to better understand the biology of mutant proteins found 
in cancer. By comparing the differences between the wild-type and R208Q versions of Gαi1, we 
are able to better understand the altered G-protein signaling and attempt to elucidate a 
mechanism for cancer progression associated with this mutant protein. We hope these results 
will be useful for designing treatments for people with mutations in these genes and will expand 
our knowledge of cell signaling, which can be translated to other systems or cancers.  
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CHAPTER TWO 
COMPARISON OF THE STRUCTURE-FUNCTION RELATIONSHIPS IN WILD-TYPE Gαi1 AND IN ITS 
R208Q MUTANT  
 Heterotrimeric G proteins are composed of α, β, and γ subunits that act as binary 
switches oscillating between “on” and “off” states, amplifying extracellular signals into the 
cytoplasm in the form of secondary messengers. G-proteins work synergistically with receptors 
at the surface of the cell. In the inactive conformation, complexes are formed between G-protein 
coupled receptors (GPCR) and a GDP-bound heterotrimer. When an extracellular ligand binds to 
a specific receptor, a conformational change ensues, causing the Gα subunit to exchange GDP for 
GTP, and release the receptor and the Gβγ subunit. The Gα protein further relays the signal 
through direct interactions with effector proteins until GTP is hydrolyzed, which results in a 
return to the inactive state (5, 6).  
 Folding in Gα proteins is highly conserved and consist of two domains: an α helical 
domain and a GTPase domain (6). The former is composed of six α helices and is important for 
effector and regulator selectivity (6). The GTPase domain is similar in structure and function to 
those of the Ras superfamily and contains six β sheets at the core surrounded by five α helices 
(31). This domain houses the nucleotide binding site, which contains a Mg2+ cofactor, and is 
surrounded by three flexible switch regions designated switch I through III. The switch regions 
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contain many conserved residues that are oriented around the γ-phosphate of GTP and are 
crucial for GTP hydrolysis (98).  
Gα proteins have a relatively slow turnover rate compared to most enzymes (81, 99). The 
ability to remain active for a longer period is important to allow for appropriate signal 
propagation through interactions with an effector. The extent to which the cell responds to 
stimuli is dependent on the time the Gα subunit is in the active conformation, which in turn is 
dictated by the rate of GTP hydrolysis. Homeostasis relies on a delicate equilibrium that can be 
deleterious. Therefore, cellular signaling must be highly regulated.  
Mutations in genes that encode Gα proteins have been shown to be involved in several 
diseases, including cancer (68, 74, 100). Admittedly, cancer is not the result of any single 
mutated gene and there are a plethora of tissue-specific permutations that can give rise to 
cancer (101). Although cancer can arise from improper regulation of pathways involving many Gα 
proteins, this study focuses on the cAMP pathway, which is stimulated by Gαs and inhibited by 
Gαi1 through interactions with AC (6). Cyclic nucleotides are secondary messengers commonly 
associated with tumor progression and have been found to be either upregulated or 
downregulated, depending on the type of cancer (102).  
The R231H Gαs and the corresponding R208Q Gαi1 mutations have been reported in 
tumors of the central nervous system and large intestine, respectively (68, 103, 104). This highly 
conserved arginine is located in the switch II region, which contains residues critical for GTP 
hydrolysis. To investigate the effects of these mutations on the function of each Gα protein, GTP 
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hydrolysis studies were conducted. Gαi1 and Gαs contain Trp residues, which upon activation, 
move into more hydrophobic environments. As a result, the increase in fluorescence intensity 
can be used as an indirect measurement of protein activity (80). This phenomenon is primarily 
due to the movement of the switch II Trp residue (W211 in Gαi1 and W234 in Gαs). Exchange of 
GDP for GTP is accompanied by an increase in fluorescence which returns to the original 
intensity at a rate proportional to GTP hydrolysis (81). The steady-state rate of GTP hydrolysis is 
determined by the rate of GDP release. For obtaining the time the protein is in an active 
conformation, which is more biologically relevant when studying effects downstream in the 
signaling pathway (36), fluorescence measurements were used to calculate single turnover rates 
under conditions of pre-steady state kinetics. Malachite green was also used for measuring the 
increase in the concentration of inorganic phosphate (Pi) that was released during the course of 
a single turnover of the enzyme (105, 106). 
We investigated how the functional differences observed by fluorescence and malachite 
green assays for WT Gα proteins and their corresponding mutants could be rationalized in terms 
of structure. To determine if differences in the active conformation exist between WT Gαi1 and 
its oncogenic mutant, we solved the X-ray structure R208Q Gαi1 protein bound to GTPγS (a non-
hydrolyzable GTP analog) and compared it with that of the published WT Gαi1•GTPγS (16). 
Furthermore, to probe the microenvironments in the vicinity of the mutations that are located in 
the flexible switch II region, molecular dynamics (MD) simulations were conducted on both 
R208Q and R231H mutants, as well as on WT Gαi1 and WTGαs proteins. We found that a network 
of molecular interactions was disrupted as a result of the mutations in the switch II region, which 
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propagated to other local motifs within the protein. In the case of Gαi1, catalytic residues 
involved in Mg2+ binding and in the orientation of a nucleophilic water moved away from the 
nucleotide binding site, while the opposite was seen in the simulated Gαs mutant. Interestingly, 
the residues involved in binding to AC were left mostly unchanged for both WT Gαi1 and Gαs and 
their respective mutants.   
Using a combination of spectroscopic and in silico techniques, we were able to elucidate 
the functional consequences of oncogenic mutations in the switch II regions of Gαs and Gαi1. We 
propose that both mutants result in lower cellular concentrations of cAMP as a result of altered 
GTP hydrolysis. 
Materials and Methods 
Cloning and Mutagenesis  
 Wild-type Gαi1-C-His6x from rat and wild-type bovine Gαs-C-His6x have previously been 
cloned into DpnI in the pQE-60 vector (Qiagen) via restriction sites and co-transformed into BL21 
E. coli with the pREP4 repressor plasmid. Site-directed mutagenesis was performed to create the 
R208Q Gαi1 point mutation using the QuikChange II kit (Agilent) and the forward, 5′′- GCC CAG 
AGA TCA GAG CAG AAG TGG ATT CAC -3′’, and the reverse, 5′′- GTG AAT CAA CTT CTG CTC TGA 
TCT CTG GCC -3′′, primers, which introduces a c.G623A mutation. The R231H Gαs mutant plasmid 
was purchased from Bio Basic in the pQE-60 vector and was subcloned into BL21 E. coli cells 
containing a pREP4 repressor plasmid. 
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Expression, Purification, and Preparation of Gα proteins 
Recombinant proteins were expressed and purified as described (107) to a purity of ≥ 
95% and stored at -80 °C. All purified proteins were subject to a time - based fluorescent 
emission assay to ensure proper activity prior to any further functional assays.  
Mg 2+-free Gα•GTPγS proteins were prepared by dialysis for six hours in 50.0 mM TrisCl 
pH 8.0, 0.005 % n,octyl-β-D-glucopyranoside, 1.0 mM EDTA, and 10.0 mM DTT, and again in 50.0 
mM TrisCl pH 8.0, 0.01 mM GTPγS, and 10.0 mM DTT for an additional six hours.  
Fluorescence Assays for Nucleotide Binding and Hydrolysis 
  Experiments were performed with a PTI QuantaMaster fluorimeter (Photon 
Technologies, Inc., Mirmingham, NJ). Time-based assays were conducted with excitation and 
emission wavelengths set at 280 nm and 340 nm, respectively. Apo Gα•GDP was incubated with 
20.0 μM GTP for 3 hours at 20.0 °C to exchange GDP for GTP.  
Malachite Green Assay 
 Malachite green (Abcam) assays were performed on a Biotek ELx808 microplate reader 
OD. An aliquot of 10.0 μM Apo Gα•GDP was incubated with 5.0 μM GTP for three hours at 4°C 
(50.0 mM HEPES pH 7.4, 2.0 mM EDTA, 100.0 μM GTP, 1.0mM DTT, and 0.2 mg*mL-1 BSA). 
Following GTP exchange, 1.0 mM MgSO4, and 40.0 μM GTPγS were added to the reaction 
mixture. After 10 minutes, the reaction was quenched with 30.0 μL malachite green and 
protected from light for 30 min. Pi was then determined by addition of 230.0 μL to a 96 – well 
plate using phosphate standards.  
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Crystallization Conditions, Data Collection and Structure Determination 
 Purified R208Q Gαi1•GTPγS was crystallized by using the hanging drop vapor diffusion 
method under slightly modified conditions (108). The total drop size of 6.00 μL was composed of 
4.80 μL protein solution (7.0 mg*mL-1 Gαi1•GTPγS, 80.0 mM HEPES pH 7.4, 120.0 mM succinic 
acid, 8.0 mM DTT, 1.0 mM GTPγS, and 25.0 mM MgSO4) and 1.20 μL reservoir solution (2.0 M 
(NH4)2SO3 pH 8.0). Aliquots of 1.0 mL reservoir solution were placed in each well of a 24 – well 
plate (VDX). Crystals formed after six days at 20 °C. The R208Q Gαi1•GTPγS crystals with the best 
morphology were transferred into a cryo-protectant (well solution supplemented with 25% (v/v) 
glycerol) before being flash cooled in liquid nitrogen. 
Monochromatic data sets were collected at the LS-CAT, Advanced Photon Source (APS) at 
Argonne National Laboratory (ANL). Diffraction data was collected at a wavelength of 0.98 at 
100K using a Dectris Eigen 9M detector. All data sets were indexed and integrated using 
HKL2000 . The best data set was processed to a resolution of 2.07Å. Data collection statistics are 
summarized in Table 3. 
The structure of R208Q Gαi1•GTPγS was solved by molecular replacement using PHASER 
in the Phenix software suit (109). The initial search model was based on a previously published 
structure of WT Gαi1•GTPγS (PDB code: 1GIA). Model building was performed using Coot and 
refined using Phenix and the structure was analyzed using Coot and UCSF Chimera (110). Final 
refinement statistics are presented in Table X (PDB code: XXXX). Structural figures were created 
using UCSF Chimera (110). 
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Molecular Dynamics Simulations 
 The coordinates of Gαi1•GDP (PDB ID: 1BOF,(86)) and Gαi1•GTPγS (PDB ID: 1GIA, (16)) 
were downloaded from the Protein Data Bank (PDB, (111)). Missing loops in the Gαi1 structures 
were modeled using Swiss-Model (112) and the corresponding transducin structures (PDB ID: 
1TAG,(13), 1TAD, (113) and 1TND,(15)). The simulations were done using procedures previously 
described (95). Unrestrained dynamics were run for 14 ns before the data were acquired for an 
additional 1 ns. The simulations were done at 37 °C (310 K) and 50 °C (328 K). These data were 
then used in the analyses. The R231H point mutation models were generated using VMD (114) 
and subjected to the same equilibration procedure as the wild-type structures. All molecular 
graphics diagrams were generated using UCSF Chimera (110). Pairwise Van der Waals and 
electrostatic interaction energies were calculated using nanoscale molecular dynamics (NAMD) 
(115). The solvent accessible surface area (SASA) was measured with the SASA routine in VMD. 
The values presented in Table 4 and in Figure 13 and Figure 14 were calculated for the final 1 ns 
in each simulation and then averaged. The simulation was equilibrated for 15 ns, and the 
interaction energy (Ei) between networking residues were calculated using NAMD. 
Results and Discussion  
Fluorescence Changes Resulting from Nucleotide Exchange 
 To determine if the oncogenic mutations affected GTP binding, we measured the rates of 
GDP exchange for GTPγS (a non-hydrolyzable GTP analog) in WT and mutant proteins. Time-
based intrinsic tryptophan fluorescence is a surrogate measure of Gα protein activity (80). 
Activation with nucleotide triphosphate results in an increase in fluorescence intensity 
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emanating from a change in the environment surrounding tryptophan residues to one that is 
more hydrophobic. Upon the addition of GTPγS, both WT Gαi1 and WT Gαs showed an increase in 
fluorescence intensity of approximately 35-40 % over a 100 min timespan (Figure 9A and B), 
which is within the expected range of 30-35 % for GTPγS activation reported in the literature 
(80). The mutants showed impaired increases in fluorescence intensity compared to their 
respective WT counterparts: the R208Q Gαi1 mutant exhibited an approximate increase of 20 % 
(Figure 9A), while the R231H Gαs mutant showed a 25 % increase (Figure 9B). W211 in Gαi1 and 
W234 in Gαs are the major contributors toward the intrinsic fluorescence of these proteins (95). 
The differences in the maximal fluorescence intensities between the WT proteins and their 
respective mutants can be attributed to these specific Trp residues moving into environments 
with different levels of hydrophobicity.  
The pseudo first-order rate of GTPγS exchange is limited by the rate of dissociation of 
GDP (kapp) (116). Using a similar analysis for the rate of change in fluorescence that was 
previously described (83, 117), the calculated kapp values for WT Gαi1 was 0.03 min-1 and 0.02 
min-1 for the R208Q mutant (Table 2). Under the same conditions, the WT Gαs showed a GTPγS 
exchange rate of 0.52 min-1 whereas, for the R231H mutant, kapp was 0.27 min-1 (Figure 9). 
Although the kapp values previously reported for Gαs are approximately two-fold higher, 0.28  
min-1 vs our observed 0.13 min-1, respectively (118)), their ratio is similar to that in our study, 
which might be due to the different methodology used and experimental conditions. In 
conclusion, both Gα mutants showed a decreased nucleotide exchange rate, but they were still 
able to bind GTP and attain the active conformation.  
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Figure 9. Changes in time-based fluorescence emission resulting from exchange of GDP for GTPγS 
bound to Gα proteins. Fluorescence intensities were normalized to zero upon nucleotide addition. (A) 
WT Gαi1 (black) vs R208Q Gαi1 (red). (B) WT Gαs (gray) vs the R231H mutant (blue). 
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Fluorescence Changes Resulting from GTP Hydrolysis 
 G-proteins function as molecular switches that turn on or off cellular responses. 
Therefore, the rate of GTP hydrolysis is what dictates the magnitude of the cellular response. 
Because the rate for nucleotide exchange is much slower than for hydrolysis, the steady-state 
turnover rate is largely determined by the release of GDP (81). All GTPases require a Mg2+ 
cofactor to function, and a highly conserved Ser is critical for Mg2+ coordination and holding it in 
the nucleotide binding site (13). In the GTPγS conformation, Mg2+ has an octahedral geometry 
and in addition to a Ser residue, is coordinated to a Thr residue, the β and γ phosphates of the 
nucleotide, and two water molecules. Uncoupling the conformational change from GTPase 
activity is critical for investigating the time the protein remains in the active state because it 
bypasses the much slower rate of nucleotide exchange (36).  
The single turnover rate of GTP hydrolysis was measured using two indirect, pre-steady-
state techniques. The fluorescence approach that was first used monitored the change in the 
hydrophobicity of key tryptophan residues that track conformational changes. As Mg2+ was 
added to apo Gα•GTP, the fluorescence intensity increased as a result of burial of Trp residues in 
the active state, but it quickly returned to zero as the bound GTP was hydrolyzed to GDP and 
inorganic phosphate (Pi) (Figure 10A, inset) (81). The half-life (t1/2) of the decay process was 
found to be 13.9 s for WT Gαi1 (Figure 10A) and 11.9 s for WT Gαs (Figure 10B). From t1/2, kcat 
values were calculated from the equation: kcat = ln(2)*t1/2-1, resulting in a kcat of 2.9 ± 0.2 min-1 
for WT Gαi1 and 3.4 ± 0.5 min-1 for WT Gαs (Table 2). 
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Figure 10. GTP hydrolysis monitored by time-based fluorescence emission. Due to 
differences in Trp environments, the maximal fluorescence intensities of WT and 
mutant proteins were different. The decays were therefore normalized to a range of 
0 to 100. The assay was initiated by addition of Mg2+ at time zero (inset). (A) WT Gαi1 
(black) vs R208Q Gαi1 (red). (B) WT Gαs (gray) vs R231H Gαs (blue). 
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Previous research showed the rate of hydrolysis for WT Gαi1 to be 0.42 min-1 (36, 119), but upon 
the addition of RGS4, a GTPase activating protein (GAP), it was found to increase from 2.0 to 4.0 
min-1 via stabilization of the transition state (116, 119-121). WT Gαs shows a turnover rate 
comparable to Gαi1 at 3.4 ± 0.5 min-1 (Table 2), and with the value that was previously reported, 
3.5 min-1 (122). A malachite green assay was also used to confirm the fluorescence 
measurements. With this technique, the kcat value for Pi formation resulting from GTP hydrolysis 
was found to be 3.0 ± 0.1 min-1 for WT Gαi1 while for WT Gαs it was 3.6 ± 0.2 min-1 (Table 2). The 
R208Q Gαi1 showed lower kcat values by both methods: 1.5 ± 0.3 min-1 using fluorescence 
spectroscopy and 1.9 ± 0.3 min-1 with malachite green, indicating that the mutant has 
diminished hydrolytic activity. Conversely, the R231H mutant showed higher rates of GTP 
hydrolysis compared to WT Gαs with kcat values of 4.8 ± 0.2 min-1 and 4.4 ± 0.9 min-1 for the 
fluorescence and malachite green assays, respectively (Table 2).  
Structure of the R208Q Gαi1 mutant 
 The R208Q Gαi1 structure was solved by molecular replacement using a previously 
published structure of the WT Gαi1•GTPγS (PDB code: 1GIA ) (Figure 11)). The data was 
processed in the space group P 32 2 1, refined to a final Rwork/Rfree (%) 16.8/19.7 and, to a 
Table 2. Pseudo first-order rate constants for GTPγS exchange and GTP hydrolysis. 
Protein GTP exchange GTP hydrolysis Pi formation
WTGiα1 0.03 ± 0.01 2.9 ± 0.2 3.0 ± 0.1
R208Q Giα1 0.02 ± 0.01 1.5 ± 0.3 1.9 ± 0.3
WTGsα 0.52 ± 0.03 3.4 ± 0.5 3.6 ± 0.2
R231H Gsα 0.27 ± 0.02 4.8 ± 0.2 4.4 ± 0.9
Rate constants given in units of min-1
Errors reported as standard deviations, n≥3
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resolution of 2.07 Å. The final refinement statistics were done by Dr. Mascarenhas and are 
shown in Table 3. The X-ray crystal structure of the R208Q Gαi1 mutant closely resembles the 
previously solved WT Gαi1 structure (PDB entry 1GIA (16)). The most pronounced changes occur 
within the switch II region where the mutation is located. Arg is a longer residue than Gln, as 
shown by the electron density in the R208Q mutant, which properly correlates to a Gln residue 
length at the 208 position. In the WT protein, R208 forms a salt bridge with E245 of the α3 helix 
but because Gln is not charged, E245 in the R208Q mutant is only capable of hydrogen bonding 
with E245, thereby weakening the interaction between the switch II and α3 helix (Figure 11). 
Furthermore, R208 of the WT protein forms a hydrogen bond with R205 (also in the switch II 
region), constraining it away from the nucleotide binding site. Because Q208 is shorter, this 
hydrogen bond is not possible, allowing R205 to freely rotate. Compared to the WT Gαi1 protein, 
the R208Q mutation causes the Cα of the Q208 residue to move slightly toward the α3 helix by 
approximately 0.7 Å.  
Superimposition of the WTGαi1•GTPγS and the R208QGαi1•GTPγS structures revealed a 
root mean square deviation (RMSD) of 0.632 Å at the site of the mutation, but only 0.255 Å 
between 345 aligned alpha carbons (Cα) in the overall proteins. However, the functionally 
important motifs saw relatively more deviation from the WT. The RMSD of the switch I region 
(residues 177-183) is approximately 70% greater (0.367 Å). Focusing only on the switch II motif 
(residues 202-215), the RMSD drastically increases to 0.453 Å. The switch III region (residues 
232-240) experiences a minor increase with an RMSD of 0.292 Å. The α4-β6 loop, which is 
important for effector binding and is located near the posterior surface relative to the nucleotide 
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binding site, has an RMSD value of 0.244 Å. These 
calculations suggest that the microenvironments in 
the immediate vicinity of the mutation are altered 
while the distal motifs are left unperturbed. Given 
that the mutation is located on the flexible switch 
II region and is positioned near the similarly 
flexible switch I region, these results are not 
surprising. Because we were unable to obtain 
crystals for R231H Gαs, a similar analysis was not 
possible.  
 
Table 3. Refinement statistics of R208Q Gαi1 crystal structure  
Space group
Cell dimension
α, β, γ (deg)
a, b, c (Å)
Resolution (Å)
Rmerge 
a (%)
I/σ (I)
Rpim 
c (%)
CC ½ d
Completeness (%)
Multiplicity
No. Reflections
No. Unique Reflections
Rwork 
e/Rfree 
f(%)
No. of Atoms
protein
ligand
water
B factors
protein
RMSD
bond lengths (Å)
bond angles (deg)
Ramachandran plot (%)
most favored
allowed
outliers
aRmerge = Σ|Iobs − Iavg|/ΣIavg.
b The values for the highest-resolution bin are in 
parentheses.
d Pearson correlation coefficient of two “half”data 
cPrecision-indicating merging R 
eRwork = Σ|Fobs − Fcalc|/ΣFobs 
f Five percent of the reflection data were selected at 
random as a test set, and only these data were 
used to calculate R free.
0
Refinement
Data Proc essing
0.002
0.476
98.4
1.6
2565
32
207
28.9
10.7(8.0)
258246
24084
16.8/19.7
2.07
7.4(65.0)b
33.1 (2.8)
2.2(22.9)
0.999(0.871)
100.0(100.0)
P 32 2 1
90.0, 90.0, 120.0
79.5, 79.5, 105.4
  
4
1 
Figure 11. Structure of R208Q Gαi1•GTPγS (teal) superimposed on the structure of WT Gαi1•GTPγS (PDB ID 
1GIA, gray). Mg2+ (green) and GTPγS bind at the active site, which is surrounded by the three switch regions 
and the P-loop (above). The interaction between the switch II and the α3 helix are weakened resulting in the 
weakened interaction between the two motifs which also leads to R205 becoming mobile (right).  
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Computer Modeling of Intermolecular Interactions 
 G-proteins are highly conserved proteins both at the primary and the secondary structure 
levels. Key residues for GTP hydrolysis by Gαi1 have been identified: R242 (123), E43 (123), and 
S47 (124) (Figure 12). These residues are known to make up an intricate network involving 
hydrogen bonds, electrostatic interactions, and hydrophobic forces. R178 has been shown to be 
directly involved in hydrolysis by stabilizing the negative charge on the γ-PO42- (16). Solving the 
crystal structure for the R208Q Gαi1 mutant provided the opportunity for using computer 
modeling to probe intermolecular interactions in a dynamic state. It has been reported that the 
R208A Gαi1 mutant has an insignificant effect on GTP hydrolysis (36). This mutant proved to be 
useful in understanding the interactions present in GTP hydrolysis. We were able to model the 
R208A Gαi1 mutant after the previously solved WT Gαi1 structure (16). Although we were unable 
to obtain crystals for the R231H Gαs protein, the mutation was also simulated from the 
previously solved WT structure (52).  
As WT Gαi1•GTPγS shifts into the active conformation, a π-cation interaction is formed 
between R208 and W211, which contributes to the stability of the switch II region (85, 95). A 
similar interaction in WT Gαs occurs between the corresponding R231 and W234 residues. 
Following our MD simulation, the RMSD between the Cα of the 208 residue in Gαi1 became 3.82 
Å and 1.3 Å for the corresponding 231 position in Gαs, which suggests that the region around the 
mutation has become unstable in the Gαi1 but much less so in Gαs.  
We calculated interaction energies to determine if the destabilization of the switch II 
region propagated to the switch I and the α3 helix regions and, if present, how it affected the 
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specific interactions involved in GTP hydrolysis (Table 4). R242 in WT Gαi1 is located at the other 
end of the α3 helix relative to the affected W258. Its interaction with E43 has been shown to 
promote the transition to the active state and allow for nucleotide exchange (123). The WT 
Gαi1•GTPγS had a total interaction energy (sum of electrostatic and van der Waals) of -60.1 
kcal*mol-1 at a distance of 3.0 Å between R242 and E43, while, for the R208A Gαi1 mutant, the 
value was -62.3 kcal*mol-1 at a similar distance. The R208Q Gαi1 mutant exhibited an interaction 
with a magnitude of approximately half (-30.8 kcal*mol-1) of the WT protein at an increased 
distance of 5.2 Å (Table 4). The Gαs counterparts are R265 and E50. Table 2 shows that the 
corresponding interactions in Gαs remained unchanged as did the inter-residue distances.  
The P-loop is located near the β and γ phosphates of GTP and is a critical motif for the 
transition to the active state. In the inactive GDP-bound conformation, it forms an electrostatic 
interaction with the catalytic R178 Gαi1 (R201 Gαs) that is known to stabilize the leaving Pi in the 
switch I region (16, 117). A key difference between heterotrimeric Gα proteins and their Ras 
counterpart is the noticeable lack of an equivalent Arg in the latter. Ras proteins have 
significantly lower rates of basal GTP hydrolysis, however, the rate is dramatically increased by 
GTPase Activating Proteins (GAP), which contains a functionally equivalent switch I Arg (125). For 
WT Gαi1 and R208A Gαi1 proteins, E43 was at a distance of 4.6 Å or 5.1 Å from R178 and with 
similar interaction energies. In the R208Q Gαi1 mutant, E43 was positioned between the 
nucleotide and R178 at a much shorter distance (1.8 Å), resulting in a strong electrostatic 
interaction of -92.0 kcal*mol-1 (Table 4 and Figure 12A). For WT Gαs and R231H Gαs, both E50 and 
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R201 remained at comparable distances (Table 4 and Figure 12B) to that between E43 and R178 
in WT Gαi1, 4.0 and 4.8 Å, respectively, vs. 4.6 Å.  
Simulating the interaction between the R178 and γ-PO42- resulted in an Ei of -100.0 
kcal*mol-1 for WT Gαi1 and -72.7 kcal*mol-1 for R208A mutant at a distance of 2.8 Å for both. The 
R208Q interaction was drastically decreased to -27.0 kcal*mol-1 at a distance of 5.6 Å (Table 4). 
Therefore, the increased interaction with E43 hinders R178 from binding to γ-PO42- (Figure 12A). 
Gαs experienced the opposite trend where WT interacted with γ-PO42- with an Ei of -40.8 
kcal*mol-1 at a distance of 6.9 Å while the R231H mutant exhibited an attraction of -103.5 
kcal*mol-1 at a distance of 3.4 Å. In neither case, however, was there any structural hindrance of 
the Arg residue with γ-PO42-, as seen in Gαi1.  
Also in the P-loop are highly conserved Ser residues necessary for Mg2+ binding: S47 in 
Gαi1 and S54 in Gαs. Across all three Gαi1 simulations, this interaction was minimally altered: -38.9 
kcal*mol-1 for WT Gαi1, -30.2 kcal*mol-1 for R208Q Gαi1, and -30.3 kcal*mol-1 for R208A Gαi1, and 
the difference in the movement was 0.1 Å (Table 4and Figure 12A). Gαs underwent a more 
drastic change in which the R231H mutant showed an increased affinity for the Mg2+ ion with an 
Ei of -46.9 kcal*mol-1 vs -29.7 kcal*mol-1 seen in the WT protein. GTPase activity has been shown 
to be regulated by Mg2+ concentration (126), therefore the increased affinity for Mg2+ could be 
contributing to the higher rate of GTP hydrolysis seen in the R231H mutant. The R208Q mutation 
affected Gαi1 through perturbations in the α3 helix, and propagated to the P-loop and the switch 
I region, which ultimately prevented R178 from interacting with γ-PO42-. Conversely, the α3 helix 
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was not affected significantly in the R231H Gαs mutant, however, R201 in the switch I region and 
in the S54P-loop moved closer to the γ-PO42- and Mg2+, respectively.  
A)  R178 
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Figure 12. Superposition of the WT and mutant nucleotide binding sites after simulation. (A) R208Q 
Gαi1 mutant (teal) and WT Gαi1 (gray). (B) R231H Gαs mutant (blue) and WT Gαs (gray). Mg2+ is shown 
in green and the phosphates of the nucleotide are depicted in orange. 
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Gαi1     Gαs    
 Interaction Energy  Distance (Å)   Interaction Energy  Distance (Å) 
Interaction WT R208Q R208A  WT R208Q R208A  Interaction WT R231H  WT R231H 
R242 - E43 -60.1 -30.8 -62.3  3.0 5.2 2.0  R265 - E50 -87.2 -84.6  2.1 2.0 
E43 - R178 -33.0 -92.0 -32.0  4.6 1.8 5.1  E50 - R201 -34.6 -32.0  4.0 4.8 
R178 - γPO42- -100.0 -27.0 -72.7  2.8 5.6 2.8  R201 − γPO4¯ -40.8 -103.5  6.9 3.4 
Mg 2+ - S47 -38.9 -30.2 -30.3  2.2 2.3 2.1  Mg 2+ - S54 -29.7 -46.9  2.2 2.0 
Interaction Energy reported in kcal*mol-1 
Table 4. Interaction energies and distances between networking residues that are involved in GTP hydrolysis. Interaction energies calculated are a combination of electrostatic and 
Van der Waals interactions 
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Within the switch II region, an interaction between F215 and W258 in the WT Gαi1 seems 
to be missing in the R208Q mutant, which causes the α3 helix to shift away compared to WT. 
This interaction is not found in WT Gαs and therefore the α3 helix is left largely unperturbed.  
In both proteins, Q204 in Gαi1 (Q227 in Gαs) is believed to be crucial for hydrolysis to 
occur via interactions with a nucleophilic water (6). Our simulations are inconclusive as to 
whether the catalytic Q204 is affected by the R208Q mutation because this residue may orient 
the nucleophilic water but cannot be observed in a water box and remain in the nucleotide 
binding site. We attempted to use the nucleotide as a reference point but the modeled R208A 
Gαi1 interaction energies were not significantly different from those for the R208Q Gαi1 mutant, 
which is not consistent with the known similarity of the rates of GTP hydrolysis of WT and R208A 
proteins.  
There are currently no crystal structures of Gαi1 in complex with AC but the contact 
residues have been identified as E207, R208, K209, and I212 from the switch II region, and K312, 
R313, K314, K315, T316, and E318 of the α4-β6 loop (52). To determine if the oncogenic 
phenotype is a result of an inability to properly bind AC, the surface accessible surface area 
(SASA) values for the Gαs-AC complex interface were compared to those for WT Gαi1 and its 
R208Q Gαi1 mutant alone (Figure 13A). Of these, only the R313 and K314 residues have 
significantly different SASA values. WT R313 has a SASA value of 156.9 ± 13.4 Å2 and is less 
exposed to solvent than R313 in the R208Q mutant, which has a SASA of 178.5 ± 12.6 Å2. The 
SASA value of K314 in WT Gαi1 was 56.5 ± 8.2 Å2 vs 102.3 ± 12.6 Å2 in the R208Q mutant. The 
difference in SASA between the WT and R208Q proteins is -34.9 Å2, suggesting that the interface 
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between the R208Q Gαi1 – AC would be largely left unaltered, and the interaction with AC would 
be similarly efficient. Using the overall SASA values to estimate the relative strengths of the 
WTGαi1 – AC and R208Q Gαi1 – AC interfaces is limited by the fact that the calculations are based 
on models rather than on actual structures of Gαi1 complexes. This assessment also fails to take 
into account the post-translational myristoylation at glycine 2 that has been shown to be 
necessary for Gαi1 to bind AC (22).  
Although Gαs undergoes a post-translational lipidation in which a palmitoyl group is 
added to the N-terminus that allows it to bind the membrane, however, it is not necessary to 
bind AC (23). A crystal structure of Gαs in complex with AC has been solved (PDB ID 1AZS) and the 
interface is known. R231, R232, W234, Q236, N239, L272, N279, R280, W281, L282, R283, and 
T284 have been shown to interact with the C2 domain of AC (54). In vivo studies have previously 
shown that the R231H Gαs mutation decreases cAMP accumulation (118, 127). Furthermore, it 
has been shown that the R231H mutation does not inhibit binding of Gαs to AC (118). Using the 
structure of WT Gαs complexed with AC (54), we were able to confirm these results by modeling 
the interface residues. The sum of the interactions between interface residues was -192.9 
kcal*mol-1 for WT Gαs and -191.5 kcal*mol-1 for the R231H mutant (Figure 14). Additionally, the 
SASA of Gαs alone was comparable to the results seen in Gαi1, the surface area of all the residues 
that contact AC was not changed significantly (Figure 13B). These calculations agree with those 
findings by showing that since the R231H Gαs mutant shows an increased rate of GTP hydrolysis, 
the overall duration of the stimulating Gαs – AC interaction would be shorter, therefore, resulting 
49 
 
in decreased cAMP production by AC. Conversely, the lower GTPase activity of Gαi1 results in a 
longer inhibiting Gαi1 – AC interaction that would also lead to lower cAMP concentrations.  
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Figure 13. SASA of the residues that interact with the C1 domain of AC. A) WT Gαi1 (black) vs R208Q Gαi1 (red) B) 
WT Gαs (gray) vs R231H Gαs (blue). Values given in Å2, and errors reported as standard deviation. 
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Conclusion  
The crystal structure of the R208Q Gαi1 mutant is similar to the WT but important 
differences in the switch regions likely affect the function of the protein. Using two indirect 
experimental approaches, we showed that the GTPase activity is decreased in the Gαi1 mutant 
but increased in the Gαs mutant. MD simulations suggest that the microenvironments in the 
vicinity of the mutations are altered thereby affecting the interaction of key residues in the 
nucleotide binding site. In R208Q Gαi1, the energy of the interaction between E43 and R178 
increased hindering catalysis by preventing the guanidinium group of the R178 from stabilizing 
the negative charge on the leaving Pi. R231H Gαs is affected in the opposite manner with an 
increase in Ei between the comparable R201 and γ-PO42- compared to the WT protein, which is 
amplified by the increased Ei seen between S50 and the Mg2+ cofactor. Modeling the binding site 
of Gα proteins and AC shows that the interface is minimally affected suggesting that the 
Figure 14. Interaction energies between Gαs and AC modeled from 1AZS structure. WT Gαs (gray) vs 
simulated R231H Gαs (blue). Units of kcal*mol-1, errors reported as standard deviations. 
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differences in cAMP accumulation reported by in vivo studies are primarily a result of changes in 
the rates of GTP hydrolysis.  
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CHAPTER THREE  
PROTEIN FOLDING OF THE R208Q MUTANT 
Guanine nucleotide-binding proteins (G-proteins) are regulatory membrane-bound 
proteins that play an indispensable role in transferring extracellular information across the cell 
membrane to affect intracellular events. G-proteins are heterotrimeric in that they are 
composed of an α subunit (Gα), which regulates the activity of the effector protein, and a βγ 
subunit complex (4). Inactive Gα subunits are complexed with G-protein coupled receptors, that, 
once activated by specific ligands, induce conformational changes in the Gα subunits, which 
prompt the exchange of guanosine 5’-diphosphate (GDP) for guanosine 5’-triphosphate (GTP) 
and the dissociation of the βγ dimer (128-130). An α-subunit regulates the appropriate enzyme 
through direct contact. This process is self-regulated, with hydrolysis of bound GTP to GDP 
effectively deactivating Gα and reforming the heterotrimeric G-protein (128).  
G-proteins are involved in stimulus-sensitive signal transduction pathways that have been 
fine-tuned to allow the cell to respond to changes in the environment. Disruptions in this balance 
may lead to disease states. While there are four families of Gα proteins (8), we limited this study 
to Gαi1 and Gαs, which regulate the activity of adenylyl cyclase (AC) (Figure 15) (131). Gαs, 
encoded by the GNAS gene, up-regulates the synthesis of the secondary messenger cyclic AMP, 
and the GNAI1 gene that encodes for Gαi1, decreases the concentration of cAMP (50). GNAS 
mutations are found in several cancers, including thyroid, large intestine, pituitary, adrenal 
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glands, biliary tract, pancreas, and the central nervous system (68, 74). Mutations in GNAI1, on 
the other hand, are associated with carcinomas in the large intestine and are found in 
hematopoietic and lymphoid tissue, and in the upper digestive tract (68). The mutations in GNAS 
and in GNAI1 genes have been observed in 4.2% and 0.4% of human cancers, respectively (68, 
104). 
One mutation of interest involves an arginine (Arg) located close to a tryptophan (Trp) in 
the conserved switch II region of Gα subunits (52, 86, 132). Figure 15 shows that the guanidinium 
group of R231 in Gαs (R208 in Gαi1) is involved in a π-cation interaction with the indole ring of 
W234 Gαs (W211 in Gαi1) when the protein is in the active conformation (13, 15, 17, 85). The 
oncogenic mutations, R231H in Gαs and R208Q in Gαi1, disrupt this interaction, which has been 
shown to be crucial for protein stability (133). Furthermore, it has been reported that the R231H 
Gαs mutation results in a decrease in cAMP production (118), although the mechanism of action is 
unknown. Loss of the π-cation interaction could cause changes in the secondary structure by 
altering the points of contact between Gα subunits and AC. Alternatively, these mutations could 
cause changes in the positions of residues vital to GTPase activity.  
The focus of this study is to gain an understanding of the structural differences on the 
protein stability of the oncogenic R231H in Gαs and R208Q in Gαi1 mutants. Several biophysical 
spectroscopic techniques was used for monitoring temperature-induced denaturation. Our 
results indicate that the Arg mutations that resulted in the loss of the π-cation interaction were 
not evident in the secondary structures at room temperature, but a decrease in protein stability 
was observed at higher temperatures. Computational methods were used to interpret the 
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structural variations in the WT Gαs and Gαi1 proteins and their corresponding mutants. 
 
Materials and Methods 
Expression and Protein Purification  
Gαi1 and Gαs were obtained and purified as previously described (95, 107). Arg single-
point mutants of Gαi1 were prepared by site-directed mutagenesis using a Quickchange II kit by 
Agilent (La Jolla, CA). Gαs mutant was purchased from Bio Basic. After purification on a Ni2+ 
affinity column followed by a Superdex 200-pg size exclusion column, the purity of GDP-bound 
Figure 15. Crystal structure of WT Gsα•GTPγS displaying its four tryptophan residues (green), fourteen tyrosine residues 
(purple), GTPγS bound nucleotide (yellow), Mg2+ (green sphere), and R234 (red) that is involved in a π-cation interaction with 
W234. (PDB ID: 1AZT)  
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Gα proteins was found to be greater than 95% as estimated by SDS – PAGE. Protein was stored at 
-80 °C in 20 mM Tris, pH 8.0 buffer containing 10% (v/v) glycerol, and 1 mM DTT.   
Fluorescence-Monitored GTPγS Exchange  
Experiments were performed with a PTI QuantaMaster fluorimeter (Photon 
Technologies, Inc., Mirmingham, NJ). Indirect activity assays were conducted with excitation and 
emission wavelengths set at 280 nm and 340 nm, respectively. Assays were initiated after 60 sec 
by the addition of 20 μM of GTPγS to pre-incubated 400 nM Gα• GDP protein samples in buffer 
containing 50 mM HEPES, pH 7.5, 2 mM MgSO4, and 1 mM DTT, and was monitored for 3 hr at 
25 °C. The GDP- and GTPγS- bound proteins that were characterized by the activity assays were 
used in the following denaturation studies.  
Fluorescence-Measured Protein Denaturation. 
Emission spectra for both GDP- and GTPγS-bound proteins were recorded over the 
wavelength range of 300 to 400 nm with the excitation wavelength set at 280 nm.  Signal 
integration time was 0.2 sec with the bandpass for excitation and for emission set at 5 nm. The 
denaturation experiments started at a temperature of 4 °C followed by 4 °C increments and 
concluding at the highest temperature before precipitation occurred.  There was a 2 min 
equilibration period at each set temperature. All Tm values were calculated from fluorescence 
intensities at the spectral λmax positions for the selected temperatures, using methods adapted 
from those previously described (134).  
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UV/Vis-Measured Protein Denaturation   
The environments of Tyr (and to a lesser extent Trp) residues in Gα proteins were 
monitored on a Hewlett Packard UV – Vis spectrophotometer.  All samples contained 50 mM 
Tris, pH 7.5, 1 μM Gα•GDP protein, 1 mM DTT, and 2 mM MgSO4.  Prior to initiating the 
experiments, samples were incubated with their respective nucleotide, 2.5 μM Gα•GDP or 20 μM 
GTPγS, at room temperature for 1 hr. The temperature was increased from 20 °C to 80°C, at 0.3 
°C*min-1 over 180 mins. For each temperature studied, samples were equilibrated for 1 min and 
the absorbance was monitored in the wavelength range of 220 – 300 nm.  All melting 
temperatures were calculated from the absorbance values at 280 nm values for the different 
temperatures, using methods previously described (135). 
CD-Measured Protein Denaturation  
Experiments were performed using an Olis DSM 20 circular dichroism 
spectrophotometer.  All samples were placed in a cylindrical quartz cuvette with a 1 mm 
pathlength and contained either 3 μM Gα•GDP or 24 μM Gα•GTPγS, in 10 mM phosphate, pH 7.5 
buffer, 1 mM DTT, and 2 mM MgSO4. Data were collected at 150 V every 1 nm in the wavelength 
range of 190 nm to 260 nm. The temperature was increased from 20 °C to 100 °C at 4 °C 
increments with an incubation time of 3 min at each temperature studied.  The CONTIN LL 
algorithm was used to deconvolute the spectra using reference sets with denatured proteins 
(97) to calculate the percent of each type of secondary structure and Tm values for each protein 
studied (136, 137).   
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Results and Discussion 
The π-Cation interaction in Gα Subunits:  
Upon activation, the Trp located in the switch II region of Gα proteins moves from a less 
hydrophobic into a more hydrophobic microenvironment, which results in a 30-45% increase in 
the fluorescence intensity (Figure 16) (85, 95)(80, 95, 138). We observed a red-shift when 
comparing the differences in wavelengths at maximal emission intensities (λmax) of the WT Gαs 
and its R231H mutant in the GDP and GTPγS conformations (Figure 17A). The red-shift was a 
result from a π-cation interaction between the positively charged guanidinium group of R231 in 
Gαs (R208 in Gαi1) with the π-electron system of W234 Gαs (W211 in Gαi1) (85, 95). Red-shifts of 
3.1 ± 0.3 nm and 3.45 ± 1.0 nm were observed at 20 °C for WT Gαs and WT Gαi1, respectively 
(Figure 17B and Figure 18). The red-shift for WT Gαs gradually decreased up to 52 °C, after which 
it became a blue-shift until precipitation occurred at 68 °C. This observation signifies that the 
electrostatic interaction between W234 and R231 weakens as the protein unfolds and severs at 
higher temperatures resulting in a blue-shift. The R231H Gαs mutation afforded a Δλmax value of 
1.6 ± 0.2 nm (blue-shift) at 20 °C, revealing a disruption of the π-cation interaction when 
compared to the WT Gαs (Figure 17B). R231H Gαs is missing the positive charge of the Arg 
residue, thus the π-electrons of W234 can no longer form electrostatic interactions and instead 
move into a hydrophobic pocket after activation. With an increase in temperature, the Δλmax 
value of the R231H Gαs mutant did not change significantly until R231H Gαs•GDP precipitated at 
72 °C, indicating that W234 does not form new interactions with other charged residues in the 
switch II region during thermal denaturation.  
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Figure 16. The microenvironment hydrophobicity surrounding W211 as it goes from it inactive to its active 
conformation. Blue represents a more hydrophilic red represents a more hydrophobic environment. From PDB: 
1GIA. 
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Similar to the WT Gαs protein, the red-shift of WT Gαi1 was inversely correlated with 
temperature, but it did not become blue-shifted as the temperature increased (Figure 18). The 
differences in the two systems could be attributed to the increased stability of the WT 
Gαi1•GTPγS compared to WT Gαs•GTPγS (139). The greater stability would require higher 
temperatures to disrupt non-covalent interactions, protecting the π-cation interaction in the 
active conformation of WT Gαi1. As for the behavior of the R231H mutant discussed above, a 
temperature-dependent decrease in the magnitude of the blue-shift would be expected for the 
R208Q Gαi1 mutant. However, a red-shift of 1.7 ± 0.7 nm was observed at 20 °C. The red-shift 
gradually declined to a negligible Δλmax value of 0.3 ± 0.8 nm until denaturation occurred at 60 °C 
(Figure 18). The measured red-shift at 20 °C was unexpected, suggesting the presence of another 
interaction mechanism for stabilization of π-electrons that was absent in the WT Gαi1, R208Q 
Gαi1•GDP, and Gαs systems.  
Figure 17. A) Normalized emission spectra of WT Gαs•GDP•Mg2+before (blue) and after (red) activation with GTPγS at 20 °C; 
B) Temperature variation of the difference between the max values of the GTPS and GDP conformations of WT Gαs (gray) 
and Gαs R231H (blue). 
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To investigate this possibility, we applied molecular dynamics to WT Gαi1 and R208Q Gαi1. 
To determine the conformation-dependent intermolecular changes that give rise to the red shift, 
we used the inactive protein as a reference to calculate the differences in the electrostatic 
interaction energies of the GTPγS and GDP conformations. For WT Gαi1 the difference in 
interaction energy between the W211 and the R208 residues is -3.98 kcal*mol-1, while, for the 
R208Q mutant, the W211-Q208 interaction is weakened to -0.84 kcal*mol-1 (Table 5) indicating 
that, because there is a weaker interaction with W211, the red-shift is unlikely due to an 
interaction between these residues (140). Further examination revealed that, for the mutant, 
Q208 has a weaker electrostatic interaction with E245 (-1.22 kcal*mol-1) at the end of the α3 
helix, than R208 in WT Gαi1•GTPγS (-79.75 kcal*mol-1), thus perturbing both the α3 helix and the 
switch II region (141). These disruptions propagate outwards towards F215 and orient it into a 
position that can interact with F199 (Figure 19). A T-oriented π-π stacking with Van der Waals 
interaction energy of -1.59 kcal*mol-1 is formed in the active conformation, which is not found in 
the WT Gαs, R231H Gαs, and WT Gαi1 systems.  
In addition to calculating interactions energies (Table 5), changes in surface area solvent 
accessibility area (SASA) when GDP is exchanged for GTP (Table 6) were also determined to gain 
Table 5. Interaction energies within residues from the WT Gαi1 and Arg mutants  
 
WT R208Q WT R208Q WT R208Q WT R208Q
-3.98 -0.84 -6.24 0.99 -10.22 0.15 4.42 6.13
-79.75 -1.22 2.28 0.04 -77.47 -1.18 2.61 5.07
0.04 -0.01 -0.16 -1.59 -0.12 -1.6 8.93 4.83
1.9 -1.05 -0.16 -0.27 1.73 -1.31 6.05 5.2
F215-F199
W258-F259
Calculated interaction are in kcal/mol
Distances  measured in Å
Electrostatic VdW Total Distances 
W211-R208(Q)
R208(Q)-E245
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insight into the interactions in these proteins. The 
change in SASA value for W211 in WT Gαi1 was -121 
Å2 compared to -57 Å2 in R208Q, but for W258, it 
decreased to -98 Å2 in the R208Q protein from -37 
Å2 in the WT Gαi1 (Table 6). Therefore, as an 
interaction between F199 and F215 is formed during activation, a gap opens up between the 
switch II region and 3 helix, allowing water to enter, thereby reducing the contribution of W211 
the fluorescence intensity as measured by an increase in SASA. The changes in SASA values 
indicate that W258 becomes the primary contributor towards fluorescence intensity at 350 nm 
as well as explains the lower intensity observed in the R208Q mutant (Figure 20). In both WT and 
R208Q proteins, the W258 residue interacts with F259 in a π-π interaction. In WT and R208Q Gαi1 
proteins, the calculated total interaction energies are relatively strong -18.47 and -16.46 
0
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Figure 18. Temperature variation of the difference between the max values 
of the GTPS and GDP conformations of carious WT Gαi1 (black) and Gαi1 
R208Q (red). 
 
Table 6. Change in SASA (Å2) exposure of W residues in 
WT Gi1 and R208Q Mutant  
 
WT R208Q
W211 -121 -57
W258 -37 -98
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kcal*mol-1, respectively (Table 5). Therefore, when W258 in the R208Q moves into a 
hydrophobic environment, a red shift is predicted as observed at 20 °C (Figure 18).  
Temperature Denaturation of Gα Proteins:  
Cation-π interactions contribute to protein stability and previous experiments suggest 
that disruptions in mutant proteins can propagate through networks of non-covalent interaction 
(87, 133, 142, 143). To gain a complete picture of the impact of disrupting π-cation interactions, 
thermal denaturation experiments were used to test the structural stability of the WT and 
mutant proteins. The melting temperatures (Tm) values were estimated for the active and 
Figure 19. Relative interresidue interactions in WT Gαi1  (gray) and in R208Q 
(green) in the GTPγS  conformation. 
E245 
W258 
F199 
F215 
W211 
R208(Q) 
Switch II 
α3 helix 
F259 
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inactive conformations of the Arg mutants and compared to the respective WT proteins. 
Denaturation was measured via the changes in fluorescence intensity and UV absorbance 
resulting from changes in the solvent exposure of Trp and from tyrosine (Tyr) residues, and from 
the change in the percent secondary structure.  
Solvent Exposure of Trp residues:  
The fluorescence emission spectra profile of the oncogenic mutants was measured 
between 20 - 80 °C. The decrease in fluorescence intensity due to the exposure of Trp to 
increasingly hydrophilic environments during unfolding was used to estimate melting 
temperatures for WT Gαs , R231H Gαs, WT Gαi1, and R208Q Gαi1 proteins (Figure 21A, Table 7). 
The fluorescence intensity of WT G1α1•GDP decreased by 53% as the protein was heated from 
20 °C to 50 °C (Figure 22A), and continued declining until 70 °C, at which point there was no 
change in intensity and the protein was fully unfolded. A Tm value of 41.1 ± 3.0 °C was previously 
Figure 20. Emission Spectra of WT (black) and R208Q (red) Gαi1 proteins in the GTPγS conformations 
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determined for WT Gαs•GDP and the 39.0 ± 1.1 °C for WT Gαi1•GDP (Table 7) (139). The observed 
fluorescence Tm values for the R231H Gαs•GDP and R208Q Gai1•GDP mutants were not 
significantly different (0.2 to 0.9 °C lower) when compared to their WT counterparts (Table 7), 
which is reflected in 52% decreases in fluorescence intensity for both mutants in the GDP 
conformation (Figure 22 A and C). The π-cation interaction only forms in the active conformation 
and the Arg residue is not involved in structurally significant interactions in the GDP 
conformation. Therefore, the loss of the stabilizing effect from the π-cation interaction would 
not be evident in non-covalent interactions in the inactive conformation (139). Although the Tm 
measurements are technique-dependent, there were no significant differences between the 
mutant and their respective WT protein in the GDP conformation (Table 7) (139).  
Table 7. Estimated melting temperature (°C) for Gα WT and mutant proteins using three spectroscopic methods. Protein variant GDP GTPγS GDP GTPγS GDP GTPγS
Gαs WT 41.1 38.7 51.9 57.4 53.5 63.7
Gαs R231H 38.8 34.8 50.9 56.3 50.5 54.9*
Gαi1 WT 39.0 48.7* 44.2 70.9* 47.6 66.5*
Gαi1 R208Q 35.1† 36.9*† 44.1 56.8*† 46.6 59.5*†
Temperatures  given in °C, S.E.M. ≤ 3, n ≥ 3 for a l l  measurements
* = P ≤ 0.05 vs  GDP-bound conformation
† =  P ≤ 0.05 vs  WT in the same conformation
Fluorescence CD UV/Vis
Protein variant GDP GTPγS GDP GTPγS GDP GTPγS
Gsα WT 41.1 ± 1.7 38.7 ± 1.0 51.9 ±  2.0 57.4 ± 1.5* 53.5 ± 1.4 63.7 ± 1.1
Gsα R231H 38.8 ± 0.5† 34.8 ± 0.8* 50.9 ± 2.7 56.4 ± 2.4* 50.5 ± 1.8† 54.9 ± 0.9*
Giα1 WT 39.0 ± 0.6 48.7 ± 2.0* 44.2 ± 0.5 70.9 ± 2.0* 47.6 ± 0.1 66.5 ± 0.2*
Giα1 R208Q 35.1 ± 2.5† 36.9 ± 0.3*† 44.1 ± 2.1 56.8 ± 1.8*† 46.6 ± 0.1 59.5 ± 0.2*†
† = Stastically different than WT with comparable conformation
Fluorescence Circular Dichroism UV/Vis Spectroscopy
Temperatures given in °C
* = Stastically different than GDP-bound conformation of same variant
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In the case of the active conformation, the melting temperature profiles for WT and 
mutant proteins are different. The Tm value for the R231H Gαs•GTPγS mutant is significantly 
lower than that of the WT in the active and inactive conformations. The Tm values for the R208Q 
Gαi1 mutant was 11.8 °C lower compared to the WT. The larger ∆Tm observed for the Gαi1 protein 
is consistent with the propagation of the destabilizing effect of the R208Q Gαi1 mutation as 
evidenced by the continued presence of a red-shift, corroborating the changes to the non-
covalent interactions. A comparison of the fluorescence intensities at 20 °C and 50 °C for R208Q 
Gαi1•GTPγS and WT Gαi1•GTPγS illustrates the drastic difference in Trp microenvironments at 
Figure 21. Temperature dependence of the A) 
Fluorescence emission spectra of R231H Gαs •GTPγS 
as a fuction of temperature (20 -100 °C) B) 
Absorption spectra of 2.5 μM WT Gαi1•Mg2+ in the 
GDP (blue) and GTPγS (red) conformations, and of 
the C) CD spectra of 1.0 μM WT Gαi1•GDP•Mg2+. 
Temperature given in °C. 
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higher temperatures. A 62% decrease in fluorescence intensity (Figure 22D) was observed for 
R208Q Gαi1•GTPγS compared to 33% decrease for WT Gαi1•GTPγS (Figure 22B).  
Solvent Exposure of Tyr residues and temperature dependence of secondary structure:   
Analogous to the fluorescence experiments, the estimated Tm values from UV/Vis 
spectrophotometry and from the secondary structures for the mutants were significantly lower 
than the respective WT proteins in the GTPγS conformation (Table 7). The ∆Tm occurred only for 
the active conformation, whereas the R231H Gαs mutant was 8.8 °C lower (Figure 21B) and the 
R208Q Gαi1 was 7.0 °C lower for UV/Vis, and, for circular dichroism (CD), R231H Gαs mutant was 
4.0 °C lower (Figure 21C) and the R208Q Gαi1 was 14.2 °C lower for CD than their WT 
counterparts (Table 7). These calculations support the hypothesis that the π-cation interaction is 
integral to the stability of Gα subunits in the active conformation and that, at higher 
temperatures, its disruption propagates outward, thereby altering the non-covalent interactions 
in the overall protein structure.  
Interestingly, the loss of the π-cation interaction results in a change in the unfolding 
progression. For the active conformation of WT Gαs, the calculated Tm values indicate that the 
denaturation initiates at the hydrophobic Trp microenvironments and then radiates toward the 
secondary structure, followed by the Tyr residues at the surface. In contrast, for the WT Gαi1, the 
disruption begins in the Trp environments, though the unfolding around Tyr residues precedes 
the loss of the secondary structure. However, both Arg mutants deviate from these paths. 
Starting from the local Trp environments, the secondary structure and the outer surface unfold 
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simultaneously, indicating that the lack of the π-cation interaction changes the propagation of 
the non-covalent network within the mutant proteins (144, 145).  
Secondary Structure Content:  
Circular dichroism was also used to probe the secondary structure content of the inactive 
and active conformations at various temperatures. The measured R231H Gαs•GDP α-helical 
content at 20 °C was 32.7 ± 1.2 % vs. 34.8 ± 1.6 % in WT Gαs•GDP, showing an insignificant 
difference in the secondary structure compared to literature values (13, 52, 86, 139). Like the 
inactive conformations, GTPγS-bound proteins exhibited an α-helical content of 33.0 ± 1.7 % for 
R231H Gαs•GTPγS vs. 36.0 ± 2.7 % for WT Gαs•GTPγS at 20 °C. The R208Q Gαi1 mutation resulted 
in similarly insignificant differences in α-helical content for the active and inactive conformations 
of the WT and mutant Gαs proteins. These results were unexpected given that there was a 
significant decrease in the stability of the arginine mutants. This suggests that, although there is 
a change in protein stability, the arginine mutation may not change the interaction with the AC 
effector. The change in the cAMP production caused by the arginine mutation is more likely due 
to a change in the rate of hydrolysis of the GTP nucleotide.  
When the temperature was increased from 36 °C to 64 °C for the active conformations of 
WT as well as for the Gαs and Gαi1 mutant proteins, the CD spectra showed a dramatic change in 
secondary structure, with a 15% – 20 % decrease in the amount of α helices. The primarily α – 
helical proteins became increasingly dominated by β – sheets, increasing from 10 % to 30 % 
(Figure 23). Temperatures above 64 °C displayed little change in the spectra and the protein 
eventually precipitated at 84 °C. 
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Neither mutation significantly diverged from their WT counterpart, as was expected from the 
previously discussed stability study. 
In the case of the active GTPγS conformations, the secondary structure of the WT and 
mutants of Gαs and Gαi1 proteins did not significantly diverge in the temperature range 20 °C to 
40 °C, but for temperatures between 32 °C and 64 °C a dramatic deviation from WT Gαs was 
observed in the α – helical content of R231H Gαs (Figure 23) and R208Q Gαi1 mutants (data not 
shown). The occurrence of unfolding in the α-helical structure at different temperatures may be 
related to the lack of the π-cation interaction in the mutant proteins.  
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Figure 22. Intrinsic Trp florescence of WT and R208Q Gαi1 proteins. Emission spectra of 0.4 μM of 
Gαi1•Mg2+ at 20 °C (blue) and 50 °C (red) of WT in the A) GDP or B) GTPγS conformations, and of R208Q 
in the C) GDP or D) GTPγS conformations.  
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Conclusion  
This study highlights the importance of the π-cation interaction towards protein stability. 
Mutations of an essential Arg residue involved in the interaction leads to a destabilization of the 
switch II region and the complete loss of the red-shift in the case of R231H Gαs. The R208Q 
mutation in Gαi1 did not abolish the red-shift with an increase in temperature, leading us to 
conclude that the decreased interaction between residues Q208 and E245 results in the 
weakening the structural integrity in the immediate vicinity of the residues. The weak Q208-E245 
interaction propagated outward, leading to the formation of an F199-F215 π-π interaction in 
R208Q Gαi1•GTPγS. As a result, the W258 residue, which is involved in a π-π stacking interaction 
with F259, moves into a more hydrophobic microenvironment thus accounting for a red-shift.  
Figure 23. Calculated % secondary structure of A) α - helices and B) β - sheets in the GTPγS conformations of WT Gαi1 
(black) and R208Q (red) as a function of temperature. 
 
70 
 
Although the mutations alter the position of several residues, they do not change the 
secondary or tertiary structures at room temperature as measured by CD. These results suggest 
that the differences in production of cAMP between WT and mutant proteins are not a 
consequence of changes in the contact points between AC and Gα subunits (118). While the 
structures are not changed at room temperatures, at higher temperatures there are significant 
decreases in the percent of α – helices. The cleavage of the π-cation interaction most likely does 
not directly modulate the levels of cAMP by altering the secondary structure, but the changes in 
the non-covalent interaction network could translate in functional modifications at the level of 
GTP hydrolysis.  
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APPENDIX A  
EFFECT OF A DOUBLE MUTANT ON THE SWITCH II REGION
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 Chapter 3 investigated the π - cation interaction between W211 and R208 present in the 
active conformations of Gαi1 proteins (85) where we demonstrated that disrupting this 
interaction had consequences for stability as measured by relative Tm values. We further 
explored this feature to determine if the proximal R205 residue can interact with W211 to create 
the π - cation interaction seen in WT and R208Q proteins. By using the same spectroscopic 
techniques as in chapter 3, we investigated whether the double mutant (R205A/R208Q) can act 
as a substitute for a π-cation interaction.  
The crystal structures of the Gαi1 proteins in the inactive GDP-bound conformation (86), 
active conformation using GTPγS (a non-hydrolyzable GTP analog) (16), as well as in the AlF4- (a 
γ-phosphate mimetic) (120), have been solved. Gα is composed of two domains: the α-helical 
domain and the GTPase domain. In the GTPase domain there are switch regions known as switch 
I, switch II, and switch III that are located near the nucleotide-binding site. The switch regions 
undergo a drastic structural change when going from the inactive GDP-bound conformation to 
the active GTP-bound conformation (146). In the GDP-bound state, switch II and switch III are 
unordered, but, upon activation, they become ordered around the γ-phosphate of GTP.  
The R208Q mutation in Gαi1 is observed in intestinal cancers (68). However, the 
mechanism by which this mutation contributes to tumor progression is not known. The Arg in 
the switch II region of the GTPase domain is involved in two events during the hydrolysis of GTP. 
First, the formation of a π-cation interaction formed with W211 (Figure 24), promoting a 
conformational change to the active state. Secondly, R208 represents an important member in a 
network of residues necessary for the binding and stabilization of GTP and magnesium (Mg2+). 
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This arginine plays a central role in the function of Gαi1. Further analysis of the structure reveals a 
similarly positioned R205 residue which is also part of a random coil in the switch II region, giving 
it the freedom to rotate freely. R205, therefore, could be a potential π-acceptor, allowing the π-
cation interaction to form and further stabilize the protein. The double mutant Gαi1 
R205A/R208Q was prepared to test this hypothesis. 
Figure 24. WT Gαi1 structure. Switch I (green) switch II (orange) and switch III (pink) undergo significant structural changes 
upon activation. This brings R208 near W211 which creates a π-cation interaction causing a red shift. 
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The focus of this study was to determine if R205 could be used as a substitute to R208 in 
the π-cation interaction in the active conformation and to compare the stability of the WT Gαi1 to 
a double mutant of the Gαi1 protein carrying both R205A and R208Q. We did this from different 
vantage points including inside the core of the protein to its surface of the protein and overall 
secondary structure. The structural stability of WT was compared to the oncogenic R208Q and 
the R205A/R208Q double mutant by measuring melting temperatures (Tm) calculated from 
several biophysical techniques.  
Gilman and colleagues have reported that fluorescence could be used as an indirect tool 
to monitor the GTPase activity of Gα-proteins (80, 81). As the protein moves into the active 
conformation, the intrinsic tryptophan fluorescence increases, while the net tryptophan 
movement is to a more hydrophobic environment. Gilman and colleagues found that a properly 
functioning Gαi1 should see a ~40% increase in fluorescence of upon activation. Unbound 
tetrafluoroaluminate (III) (AlF4¯) resembles a phosphate in size and geometry however upon 
binding, switches from a tetrahedral to square planar geometry. AlF4¯ activation does not 
require GDP exchange resulting in the first order reaction rate which mimics the transition state 
and can be measured with fluorescence. Using this technique for WT Gαi1, we also report an ~40 
% increase in following the addition of AlF4¯ (Figure 25), which is in agreement with the results 
found by Gilman (80). Activation of the R208Q and the R205A/R208Q double mutant resulted in 
significantly smaller changes in fluorescence, an approximately 28.5 % change for both mutant 
proteins (Figure 25).  
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Hamm and colleagues (85) described a red shift upon activation due to the interaction 
between R208 and W211 in the wild-type Gαi1 protein. We wished to expand on this by 
determining how the R208Q mutation would affect the red shift. We observed similar results for 
WT proteins at room temperature (with shifts of 3.45 ± 1.04 nm for GTPγS and 2.93 ± 1.25 nm 
for AMF, respectively). The red shift became progressively smaller as the temperature increased 
(Figure 26) and at 60 °C, still existed for GTPγS activation, which was 1.63 ± 1.24 nm. In contrast, 
a 0.67 ± 1.06 nm blue shift formed with AMF activation, indicating that W211 had moved to a 
more hydrophobic environment, ceasing the π – cation interaction. When measuring the red 
shift at room temperature in the R208Q mutant, the red shift persisted regardless of whether 
AlF4- (0.88 ± 0.81 nm) or GTPγS (1.67 ± 0.66 nm, chapter three) was used to activate the protein 
Figure 25: Activation with AlF4¯ of WT Gαi1 (black), R208Q Gαi1 proteins (red), and the R205A/R208Q double 
mutant (green). 
0
5
10
15
20
25
30
35
40
45
0 50 100 150 200 250 300 350
%
 C
h
an
ge
 in
 F
lu
o
re
sc
en
ce
Time (Seconds)
WT•AMF R208Q•AMF R205A,R208QR208Q•AMF
76 
 
(Figure 25). Furthermore, both the AMF and GTPγS induced red shifts disappeared at higher 
temperatures, albeit at different temperatures (Figure 26A vs B). The AMF red shift disappeared 
by 50 °C and continued to shift to a lower wavelength (blue shift) until 60 °C when the blue shift 
was 1.56 ± 0.97 nm at which point the protein became unstable. The R208Q mutant lacks the 
key arginine residue necessary for providing the positive charge needed for the π-cation 
interaction, and thus, the existence of a red shift was unexpected.  
We created the R205A/R208Q double mutant to further explore the continued red shift 
observed in the R208Q mutant. The double mutant allows us to determine if the observed red 
shift was due to this proximal Arg residue in the 205 position. Eliminating both arginine residues 
abolished the red shift and gave rise to a -2.0 to -5.0 nm blue shift at all temperatures for AMF 
activations. However, for GTPγS activations, a +1.0 nm red shift persisted at lower temperatures 
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Figure 26. Shift in maximal wavelength at 20 °C λmax vs temp. A) GTPγS vs GDP bound conformations B) AMF vs GDP 
conformations for WT Gαi1, R208Q Gαi1 and, the double mutant R205A/R208Q Gαi1. 
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and behaved similarly to the R208Q single mutant in that it was a 0.04 ± 0.63 nm blue shift by 60 
°C.  
To examine the solvent exposure resulting from the conformational change, trypsin 
digestion was used. Gilman and colleagues first noted the different cleavage patterns between 
active and inactive WTGα (116). Upon activation of the GTPγS conformation, rapid cleavage at 
the N-terminus occurs while the middle of the protein is protected (where R208 is located), 
resulting in the accumulation of 37 to 39 kDa polypeptides. GDP, on the other hand, is digested 
into relatively small fragments suggesting that R208 is cleaved only when complexed to GDP 
while becoming inaccessible in the active conformation. AMF activation leads to partial 
digestion. It is thought this is a result of increased mobility of the R208 residue causing it to be 
exposed in short intervals (95).  
Surprisingly, similar cleavage patterns were observed for the R208Q mutant, the 
R205A/R208Q double mutant and the WT. This suggests that R205 is subject to the same 
environmental changes as R208, resulting in its cleavage when in the GDP-bound conformation, 
while it remains protected in the GTPγS conformation (Figure 27, lanes 5-7). The R205A/R208Q 
double mutant was cleaved at the N-terminus but since both R205 and R208 are no longer 
cleavable by trypsin, the result is an accumulation of relatively smaller fragments (Figure 27, 
lanes 8-10).  
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To investigate the melting properties of the R208Q mutant, and to better understand the 
roles of R205 and W211, we compared three techniques: fluorescence, CD, and UV/Vis, to obtain 
a global understanding of the protein’s folding. Fluorescence measures the Trp residues at the 
core of the protein while UV/Vis depends on the Tyr residues at the surface. CD measures the 
proteins as a whole as the secondary structure changes.  
Fluorescence intensity as a function of temperature was used to determine the melting 
temperature (Tm). As the temperature increased, the fluorescence intensity decreased indicative 
of protein unfolding. In the inactive conformation, Tm WT is 39.0 °C and the Tm R208Q is 35.1 °C. 
Surprisingly, activation with AlF4- yielded insignificant changes to the Tm (p = 0.45), and all three 
proteins had Tm values around 35 °C (Table 8). Activation with GTPγS exhibits a stark contrast 
between the WT and both the R208Q mutant and the R205A/R208Q double mutant where the 
Tm for the WT protein is 48.7 °C, and the two mutant proteins are 36.9 °C.  
Computer algorithms are able to calculate Tm values from the CD spectra. We calculated 
a Tm value for WTGαi1•GDP of 44.20 °C, WTGαi1•AMF 47.50 °C, WTGαi1•GTPγS of 70.90 °C. The 
GDP conformation of the R208Q mutant and the R205A/R208Q double mutant were similar to 
Figure 27. Trypsin digest of Gα  proteins in the inactive and active conformations.  
R205A/R208Q
Q 
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that of the WT at around 44 °C. For the R208Q mutant, both active conformations show 
significantly lower melting temperatures compared to the WT protein of the same conformation 
with the AMF conformation having a Tm of 39.33 °C and the GTPγS of 56.75 °C (Table 8). The 
R205A/R208Q double mutant also had a lower Tm value compared to WT and to the R208Q 
mutant (Table 8). 
In both the inactive conformations and in the AMF active conformations of all three 
proteins, the Tm values were similar and around 47 °C (Table 8). When activating with GTPγS the 
same trend was observed; Tm of WT Gαi1 was the highest followed by the R208Q mutant and the 
R205A/R208Q double mutant was the smallest (Table 8). 
In a study of Trp mutants done previously in this lab by Najor et al (95), the W211F 
mutant was characterized. Since the π-cation interaction is thought to occur between R208 and 
W211, we thought it would be interesting to compare the results of the W211F mutant to the 
R208Q mutant. Using fluorescence, the W211F mutant had a Tm of 35.30 °C in the GDP 
conformation, 34.10 °C in the AMF conformation and 37.20 °C in the GTPγS conformation. CD 
yielded results that were inconsistent with both WT and the R208Q mutants, 54.30 °C for the 
GDP, 57.00 °C for the AMF and 56.50 °C for the GTPγS (Table 8). These results are 
uncharacteristically high for Gαi1 and may need to be reevaluated at a later time. Regardless, it is 
important to note that both active conformations are not significantly different than the GDP-
bound conformation. UV/Vis calculations are consistent with fluorescence results with Tm 
calculations of 46.80 °C, 45.78 °C, and 52.30 °C, respectively, for GDP, AMF and GTPγS 
conformations.  
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The R205A/R208Q double mutant behaves similarly to the R208Q mutant, confirming 
that the π-cation reaction does contribute a significant amount toward the overall stability of the 
protein. However, the R205A/R208Q Gαi1 double mutant follows a similar trend as the R208Q 
mutant and is similar to the R208Q mutant despite technique used leading us to believe that 
R205 is not additionally stabilizing the protein in the active conformation. Future in silico 
experiments to determine the role of the R205 residue in the stability and/or activity of the 
protein would include interaction energies of R205 with nearby residues that have been shown 
to be important for GTP hydrolysis, similar to those done in chapter 2.
Table 8. Tm estimates using three spectroscopic techniques for all three proteins is the inactive and both active conformations. 
GDP AMF GTPγS GDP AMF GTPγS GDP AMF GTPγS
WT 39.00 38.30 48.70* 44.20 47.50* 70.90* 47.60 48.60* 66.50*
R208Q 38.1 36.41 36.89† 44.10 39.33† 56.75*† 46.60 46.55† 59.52*†
R205A; R208Q 34.80 35.01 36.92† 44.05 ― 48.56*†‡ 46.33† 45.07*† 51.47*†‡
W211F 35.30 34.10 37.20† 54.30†‡ 57.00†‡ 56.50† 46.80† 45.78† 52.30†
‡ =  P ≤ 0.05 vs R208Q in the same conformation
Fluorescence CD UV/Vis
* = P ≤ 0.05 vs GDP-bound conformation
† =  P ≤ 0.05 vs WT in the same conformation
S.E.M. ≤ 3, n ≥ 3 for all measurements
Giα1 variant
― = Data not collected
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 Glycogen Synthase Kinase 3β (GSK3β) is a constitutively active serine/threonine kinase, 
which was named so because it originally was shown to regulate cellular glycogen levels through 
inhibition of glycogen synthase (GS), and is itself inhibited by insulin among others (147). 
Extensive studies have provided evidence that GSK-3 functions as an important regulatory kinase 
for at least 50 targets and is involved in a number of important roles including inflammation, 
apoptosis, embryonic development, heart function, and synaptic transmission in neurons (148-
153). Similar to G-proteins, GSK-3 has been shown to provide important regulation in an array of 
signaling pathways vital for homeostasis. 
 There are two GSK-3 isoforms, GSK-3α (51kDa) and GSK-3β (47kDa), which are expressed 
by the GSK3A and GSK3B genes, respectively. GSK-3β exists in two different splice variants GSK-
3β1 and GSK-3β2, where GSK-3β1 is a shorter variant and lacks exon 9 (a 13 residue exon) while 
GSK-3β2 is longer and does contain the 13-residue exon 9 in the catalytic domain. While GSK-
3β1 is expressed in tissues ubiquitously, GSK-3β2 is expressed exclusively in the central nervous 
system (CNS). The function of exon 9 in GSK-3β2 is still largely unknown, therefore unless 
otherwise stated, the rest of this section will be referring to GSK-3β1. 
 Serine/threonine kinases typically utilize an alpha helix and a beta sheet, which must be 
aligned into a specific conformation for activity. While GSK-3 does contain this secondary 
structure, the mechanism by which they are aligned is unique (Figure 28). Most kinases use 
phosphorylated residues in an activation domain to achieve an active conformation. GSK-3 is 
more tightly regulated and phosphorylation may inhibit or activate it depending on the 
phosphorylation site. GSK-3 is inactivated when phosphorylated at the amine terminal serine (S) 
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9 (GSK-3β) or S21 (GSK-3α). When phosphorylated at these residues, a primed pseudo-substrate 
is formed in the active site, which acts as a competitive inhibitor (Figure 28) (154). In contrast, 
phosphorylation at Tyrosine (Y) 216 or Y279 in GSK-3β or GSK-3α, respectively, seems to 
promote activity but because GSK-3 is a constitutively active enzyme, it is unknown how 
important this phosphorylation actually is for activity.  
Crystal structure analysis shows GSK-3 prefers a phosphoserine on the substrate. More 
specifically, GSK-3β recognizes the sequence S/TXXXS, in which the P + 4 serine has been 
previously phosphorylated by another kinase. When the substrate has been “primed” by a prior 
phosphorylation event, GSK-3β is found to be exponentially more efficient (155). Similar to Gα 
proteins, GSK-3 activity must be closely regulated. Cells have four mechanisms for regulating 
GSK-3: phosphorylation of GSK-3 itself, phosphorylation of the substrate, subcellular localization, 
and the formation of protein complexes (156). Natively, the most effective mechanism of 
regulation is through phosphorylation of key residues of GSK-3. Hyperactive GSK-3 has been 
linked to several devastating illnesses, including Alzheimer’s (149), diabetes (150), and cancer 
(148, 157). Inhibition of GSK-3 has, therefore, become a critical research topic. Li+ has been 
shown to inhibit GSK-3 and is effective in the 1-2 mM range (158, 159), therefore at 
physiologically-relevant concentrations, inhibition is minimally effective. Like many enzymes, 
GSK-3’s active site requires a Mg2+ cofactor to function (Figure 28). Li+ is a noncompetitive 
inhibitor of GSK-3 with respect to the substrate but evidence has shown that Li+ is a competitive 
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inhibitor with respect to Mg2+ (160, 161). This is a fairly unusual mechanism in that Li+ binds the 
enzyme-substrate complex by displacing the Mg2+ cofactor from the active site. Mechanistically, 
it is a plausible hypothesis because Li+ can compete with the native Mg2+ cofactor in the active 
site (162-164). Because both Li+ and Mg2+ are similar in atomic radius, and both are positively 
Figure 28. The crystal structure of GSK-3β has been solved. An ADP molecule is located in the active site situated around the 
Mg2+ cofactor. The basic arginine and lysine residues just next to the active site explain GSK-3β’s preference for “primed” 
substrates. PDB ID: 1J1C 
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charged, Li+ is thought to be able to fit in the active site and displace the Mg2+ ion. Because Li+ is 
a monovalent cation, as opposed to Mg2+ , a divalent cation, Li+ is unable to interact with ATP in 
the same manner, thus, inhibiting the enzyme.  
Conflicting evidence suggests that GSK-3β may have two Mg2+ binding sites (164). 
Inhibition of GSK-3β with a second and more potent inhibitor beryllium (Be2+) show a further 
reduced activity of GSK-3β. This “dual inhibition analysis” hints that there are two active sites 
present in GSK-3β but only one is sensitive to Li+. It is important to note that these studies also 
suggest that Be2+ binds to both the Mg2+ and an ATP molecule in the active site whereas Li+ does 
not interact with ATP (164).  
The goal of this research was to enhance our understanding of Li+ as a pharmaceutical 
agent by 1) gaining better insight into the effects of Li+ on the enzyme and the mechanism of 
GSK-3β and 2) to better understand the structural significance of GSK-3β and the relationship to 
Li+.  
We were able to successfully amplify both the long and short splice variants of human 
GSK-3β using PCR with DNA from the H1299 cell line (generously provided by Dr. Abde 
Abukhdeir from Rush University). The recombinant GSK3B gene was transformed into a bacmid 
in DH10Bac cells. The bacmid was transformed into sf-9 insect cells to generate baculovirus 
containing either the GSK3B1 or GSK3B2 gene, which was then used to infect naïve sf-9 cells at 
~50 % confluency for 5 days at 37 °C to create the P0 stock (Figure 29). Infected cells can be 
visually inspected as the radius of infected cells grows to be twice the size of non-infected cells 
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(Figure 30). A viral plaque assay was used to quantify 
the baculovirus titer. Once a high-titer baculovirus 
stock (with a multiplicity of infection (MOI) ≥ 1.0×108 
pfu) had been generated, the Sf9 cells were infected 
and further cultured on a larger scale to create the P1 
stocks which can be harvested for recombinant protein 
production (and Figure 31). 
Unfortunately, we were unable to scale up 
production to express large enough quantities of 
protein to use for further biophysical studies. Future 
experiments would need to determine a cost-effective 
method for gaining high-yield protein preparations. It 
would then be possible to investigate GSK-3β activity 
by the efficiency of transfer of [γ- 32P]-ATP to a 
synthetic GSM peptide substrate. Li+ vs. Mg2+ would 
then be used to compare the effect of Li+ on the 
activity of GSK-3β. Furthermore, folding studies in conjunction with X-ray crystallography might 
provide ample information with regard to the structure of GSK-3β. Although the structure has 
previously been solved, all existing X-ray structures show only one Mg2+ binding site. We would 
be able to compare the electron density at the metal binding site(s) of GSK-3β by conducting a 
crystallographic titration with Mg2+ in the presence and absence of Li+. The hypothesis is that the 
Figure 29. PCR analysis of bacterial colonies. 
Colonies at the top are expressing GSK-3β2 while 
the ones on the bottom are expressing GSK-3β1. 
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existing crystal structures only capture one Mg2+ binding site because the second binding site 
may have a much lower affinity for Mg2+, which can be displaced by Li+ under crystallization 
conditions.  
Figure 30. Transfected Sf-9 Cells under a light microscope magnified 100x. The red arrows show examples of 
infected cells which show a significant increase in cell diameter. 
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50 kDa α-GSK-3β1 
Figure 31. Western blot analysis confirms the presence of GSK-3 in Sf-9 whole cell lysate. This blot compares different 
MOI and incubation times to determine the optimal incubation conditions. 
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